×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Bausch Health Companies Inc. (BHC) NEW YORK STOCK EXCHANGE INC.

$8.60 (0.06) (-0.69%)

Market Cap: $3.13B

As of 04/18/24 04:00 PM EDT. Market closed.

(BHC)

Bausch Health Companies Inc. (BHC)
NEW YORK STOCK EXCHANGE INC.

$8.60
(0.06) (-0.69%)

Market Cap: $3.13B

As of 04/18/24 04:00 PM EDT. Market closed.

Add to Portfolio

bausch health companies inc. (nyse/tsx: bhc) is a global company that develops, manufactures and markets a range of pharmaceutical, medical device and over-the-counter products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology. we are delivering on our commitments as we build an innovative company dedicated to advancing global health. our approximately 22,000 ... read more

bausch health companies inc. (nyse/tsx: bhc) is a global company that develops, manufactures and markets a range of pharmaceutical, medical device and over-the-counter products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology. we are delivering on our commitments as we build an innovative company dedicated to advancing global health. our approximately 22,000 employees are united around our mission of improving people’s lives with our health care products, and we manufacture and market health care products directly or indirectly in approximately 100 countries.five pillars, or guiding principles, represent the foundation on which we are realizing our mission as an organization: people, quality health care outcomes, customer focus, innovation and efficiency. more information can be found at www.bauschhealth.com.### read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Thomas J. Appio
Full Time Employees
2,667
URL
Address
2150 St. ElzEar Boulevard West, QC, Laval, H7L4A8.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Thomas J. Appio
Full Time Employees
2,667
Address
2150 St. ElzEar Boulevard West, QC, Laval, H7L4A8.
PRICE CHART FOR BAUSCH HEALTH COMPANIES INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$8.59
Previous Close
$8.66
Days Range
$8.65 - $8.92
52 week range
$5.57 - $11.46
Volume
2,183,657
Avg. Volume (30 days)
4,096,798
Market Cap
$3.13B
Dividend Yield
-
P/E
(5.28)
Shares Outstanding
360,989,744
Open
$8.59
Previous Close
$8.66
Days Range
$8.65 - $8.92
52 week range
$5.57 - $11.46
Volume
2,183,657
Avg. Volume (30 days)
4,096,798
Market Cap
$3.13B
Dividend Yield
-
P/E
(5.28)
Shares Outstanding
360,989,744
FINANCIAL STATEMENTS FOR BAUSCH HEALTH COMPANIES INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR BAUSCH HEALTH COMPANIES INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Paulson JohnDirectorMar 29, 2024 Option Exercise$10.615,89062,493208,309Apr 01, 2024, 04:33 PM
ICAHN BRETTDirectorMar 29, 2024 Option Exercise$10.613,12233,124108,500Apr 01, 2024, 04:31 PM
ROBERTSON RUSSEL CDirectorMar 29, 2024 Option Exercise$10.612,94531,246225,279Apr 01, 2024, 04:30 PM
WECHSLER AMY BDirectorMar 29, 2024 Option Exercise$10.616476,865169,906Apr 01, 2024, 04:29 PM
Barresi John SSVP, Controller & CAOMar 01, 2024 Option Exercise$9.893,18831,529107,064Mar 04, 2024, 04:24 PM
APPIO THOMASChief Executive OfficerMar 01, 2024 Option Exercise$9.89116,9821,156,9521,483,443Mar 04, 2024, 04:19 PM
Carson SeanaEVP, General CounselMar 01, 2024 Option Exercise$9.8924,243239,763529,696Mar 04, 2024, 04:16 PM
Carson SeanaEVP, General CounselMar 04, 2024 Sale$9.806,31361,867501,798Mar 04, 2024, 04:16 PM
ROBERTSON RUSSEL CDirectorDec 29, 2023 Option Exercise$8.023,89631,246222,334Jan 02, 2024, 04:19 PM
ICAHN BRETTDirectorDec 29, 2023 Option Exercise$8.024,13033,123105,378Jan 02, 2024, 04:18 PM
Paulson JohnDirectorDec 29, 2023 Option Exercise$8.027,79362,500202,419Jan 02, 2024, 04:16 PM
WECHSLER AMY BDirectorDec 29, 2023 Option Exercise$8.028576,873169,259Jan 02, 2024, 04:15 PM
Carson SeanaEVP, General CounselDec 01, 2023 Option Exercise$7.361,69112,446383,145Dec 05, 2023, 04:35 PM
Carson SeanaEVP, General CounselDec 05, 2023 Sale$7.382201,624382,925Dec 05, 2023, 04:35 PM
Carson SeanaEVP, General CounselNov 03, 2023 Option Exercise$7.573342,528384,879Nov 06, 2023, 05:06 PM
Carson SeanaEVP, General CounselNov 06, 2023 Sale$7.6143327384,836Nov 06, 2023, 05:06 PM
WECHSLER AMY BDirectorSep 29, 2023 Option Exercise$8.228366,872168,402Oct 02, 2023, 04:29 PM
ROBERTSON RUSSEL CDirectorSep 29, 2023 Option Exercise$8.223,80131,244218,438Oct 02, 2023, 04:28 PM
Paulson JohnDirectorSep 29, 2023 Option Exercise$8.227,60362,497194,626Oct 02, 2023, 04:27 PM
ICAHN BRETTDirectorSep 29, 2023 Option Exercise$8.224,02933,118101,248Oct 02, 2023, 04:25 PM
Carson SeanaEVP, General CounselSep 05, 2023 Option Exercise$8.3551,337428,664391,898Sep 06, 2023, 04:33 PM
Carson SeanaEVP, General CounselSep 06, 2023 Sale$8.286,68555,352385,213Sep 06, 2023, 04:33 PM
Barresi John SSVP, Controller & CAOSep 05, 2023 Option Exercise$8.353,98233,25071,126Sep 06, 2023, 04:31 PM
Vadaketh Tom GeorgeEVP, Chief Financial OfficerSep 05, 2023 Option Exercise$8.3543,948366,966564,933Sep 06, 2023, 04:29 PM
APPIO THOMASChief Executive OfficerSep 01, 2023 Option Exercise$8.4614,111119,379967,010Sep 05, 2023, 05:09 PM
WECHSLER AMY BDirectorJun 30, 2023 Option Exercise$8.008596,872167,566Jul 05, 2023, 04:09 PM
ICAHN BRETTDirectorJun 30, 2023 Option Exercise$8.004,14033,12097,219Jul 05, 2023, 04:07 PM
Paulson JohnDirectorJun 30, 2023 Option Exercise$8.007,81262,496187,023Jul 05, 2023, 04:06 PM
ROBERTSON RUSSEL CDirectorJun 30, 2023 Option Exercise$8.003,90631,248214,637Jul 05, 2023, 04:01 PM
Barresi John SSVP, Controller & CAOJun 20, 2023 Option Exercise$7.401,92914,27575,108Jun 21, 2023, 04:10 PM
WECHSLER AMY BDirectorMar 31, 2023 Option Exercise$8.108486,869137,502Apr 04, 2023, 06:07 PM
ROBERTSON RUSSEL CDirectorMar 31, 2023 Option Exercise$8.104,11033,291181,526Apr 04, 2023, 06:06 PM
Paulson JohnDirectorMar 31, 2023 Option Exercise$8.107,71662,500150,006Apr 04, 2023, 06:04 PM
ICAHN BRETTDirectorMar 31, 2023 Option Exercise$8.103,68429,84063,874Apr 04, 2023, 06:03 PM
DE SCHUTTER RICHARD UDirectorMar 31, 2023 Option Exercise$8.103,64229,500373,407Apr 04, 2023, 06:02 PM
Carson SeanaEVP, General CounselMar 03, 2023 Sale$9.347807,285443,730Mar 07, 2023, 04:50 PM
Carson SeanaEVP, General CounselMar 06, 2023 Sale$9.174954,539443,235Mar 07, 2023, 04:50 PM
Carson SeanaEVP, General CounselMar 06, 2023 Option Exercise$9.174954,539443,235Mar 06, 2023, 04:52 PM
Carson SeanaEVP, General CounselMar 03, 2023 Option Exercise$9.194,58042,093447,545Mar 06, 2023, 04:52 PM
Carson SeanaEVP, General CounselMar 02, 2023 Option Exercise$9.255,99455,445353,191Mar 06, 2023, 04:52 PM
APPIO THOMASChief Executive OfficerMar 03, 2023 Option Exercise$9.1610,17593,203989,403Mar 06, 2023, 04:49 PM
APPIO THOMASChief Executive OfficerMar 02, 2023 Option Exercise$9.2517,432161,246468,141Mar 06, 2023, 04:49 PM
Vadaketh Tom GeorgeEVP, Chief Financial OfficerMar 02, 2023 Option Exercise$9.254,00137,009466,203Mar 06, 2023, 04:48 PM
Carson SeanaEVP, General CounselFeb 27, 2023 Option Exercise$9.572,24221,456360,245Mar 01, 2023, 05:45 PM
Carson SeanaEVP, General CounselFeb 28, 2023 Sale$9.322922,721359,185Mar 01, 2023, 05:45 PM
APPIO THOMASChief Executive OfficerFeb 27, 2023 Option Exercise$9.576,32760,549487,642Mar 01, 2023, 05:43 PM
Vadaketh Tom GeorgeEVP, Chief Financial OfficerJan 03, 2023 Option Exercise$6.286,31039,627470,204Jan 04, 2023, 04:36 PM
DE SCHUTTER RICHARD UDirectorDec 30, 2022 Option Exercise$6.285,18632,568369,765Jan 03, 2023, 05:11 PM
ICAHN BRETTDirectorDec 30, 2022 Option Exercise$6.284,58928,81960,190Jan 03, 2023, 05:08 PM
Miller Steven DDirectorDec 30, 2022 Option Exercise$6.284,58928,819110,312Jan 03, 2023, 05:07 PM
Paulson JohnDirectorDec 30, 2022 Option Exercise$6.289,95262,499142,290Jan 03, 2023, 05:04 PM
ROBERTSON RUSSEL CDirectorDec 30, 2022 Option Exercise$6.285,47334,370177,416Jan 03, 2023, 05:02 PM
WECHSLER AMY BDirectorDec 30, 2022 Option Exercise$6.281,0946,870136,654Jan 03, 2023, 04:59 PM
Carson SeanaEVP, General CounselDec 01, 2022 Option Exercise$7.701,69113,021361,719Dec 02, 2022, 04:17 PM
Carson SeanaEVP, General CounselNov 03, 2022 Option Exercise$6.453342,154363,410Nov 04, 2022, 04:06 PM
ROBERTSON RUSSEL CDirectorSep 30, 2022 Option Exercise$6.894,98934,374171,943Oct 03, 2022, 05:15 PM
Paulson JohnDirectorSep 30, 2022 Option Exercise$6.899,07162,499132,338Oct 03, 2022, 05:15 PM
WECHSLER AMY BDirectorSep 30, 2022 Option Exercise$6.899976,869135,560Oct 03, 2022, 04:49 PM
ROBERTSON RUSSEL CDirectorSep 30, 2022 Option Exercise$6.895,53338,122172,487Oct 03, 2022, 04:47 PM
Paulson JohnDirectorSep 30, 2022 Option Exercise$6.892,73218,823125,999Oct 03, 2022, 04:46 PM
Miller Steven DDirectorSep 30, 2022 Option Exercise$6.894,44430,619105,723Oct 03, 2022, 04:45 PM
ICAHN BRETTDirectorSep 30, 2022 Option Exercise$6.894,44430,61955,601Oct 03, 2022, 04:44 PM
DE SCHUTTER RICHARD UDirectorSep 30, 2022 Option Exercise$6.894,98934,374364,579Oct 03, 2022, 04:40 PM
APPIO THOMASChief Executive OfficerSep 01, 2022 Option Exercise$6.5915,389101,414491,900Sep 02, 2022, 04:35 PM
ROBERTSON RUSSEL CDirectorJun 30, 2022 Option Exercise$8.364,31436,065166,954Jul 06, 2022, 04:16 PM
Paulson JohnDirectorJun 30, 2022 Option Exercise$8.362,25118,818123,267Jul 05, 2022, 07:28 PM
ROBERTSON RUSSEL CDirectorJun 30, 2022 Option Exercise$8.364,56038,122167,200Jul 05, 2022, 06:04 PM
WECHSLER AMY BDirectorJun 30, 2022 Option Exercise$8.368226,872134,563Jul 05, 2022, 06:02 PM
Miller Steven DDirectorJun 30, 2022 Option Exercise$8.363,66330,623101,279Jul 05, 2022, 06:01 PM
ICAHN BRETTDirectorJun 30, 2022 Option Exercise$8.363,66330,62351,157Jul 05, 2022, 06:00 PM
DE SCHUTTER RICHARD UDirectorJun 30, 2022 Option Exercise$8.364,11134,368359,590Jul 05, 2022, 05:59 PM
PAPA JOSEPH CDirectorMay 10, 2022 Option Exercise$9.4033,714316,9121,427,568May 12, 2022, 09:12 PM
Spurr RobertU.S. President-Pharma BusinessApr 14, 2022 Sale$22.191,59535,39390,506Apr 15, 2022, 04:32 PM
WECHSLER AMY BDirectorMar 31, 2022 Option Exercise$22.853006,85599,354Apr 04, 2022, 06:13 PM
ROBERTSON RUSSEL CDirectorMar 31, 2022 Option Exercise$22.851,66838,114128,253Apr 04, 2022, 06:08 PM
Miller Steven DDirectorMar 31, 2022 Option Exercise$22.851,34030,61963,229Apr 04, 2022, 06:04 PM
ICAHN BRETTDirectorMar 31, 2022 Option Exercise$22.851,34030,61913,107Apr 04, 2022, 06:01 PM
DE SCHUTTER RICHARD UDirectorMar 31, 2022 Option Exercise$22.851,50434,366321,092Apr 04, 2022, 05:57 PM
Paulson JohnDirectorMar 31, 2022 Option Exercise$22.851,34030,61986,629Apr 04, 2022, 05:53 PM
Spurr RobertU.S. President-Pharma BusinessMar 15, 2022 Sale$22.204,846107,58192,101Mar 16, 2022, 04:39 PM
ACKERMANN CHRISTINAEVP AND GENERAL COUNSELMar 10, 2022 Option Exercise$22.5683918,928162,240Mar 11, 2022, 04:00 PM
Gordon Joseph FPres&Co-Head Bausch&Lomb/Int'lMar 08, 2022 Sale$21.763,88984,62593,139Mar 10, 2022, 04:03 PM
Spurr RobertU.S. President-Pharma BusinessMar 03, 2022 Option Exercise$23.614,07496,18796,947Mar 07, 2022, 05:49 PM
Munsch FrederickSVP, Controller and CAOMar 03, 2022 Option Exercise$23.6160814,35523,182Mar 07, 2022, 05:47 PM
ACKERMANN CHRISTINAEVP AND GENERAL COUNSELMar 03, 2022 Option Exercise$23.616,926163,523163,079Mar 07, 2022, 05:45 PM
Eldessouky SamEVP & Chief Financial OfficerMar 03, 2022 Option Exercise$23.611,24229,324119,455Mar 07, 2022, 05:41 PM
PAPA JOSEPH CCHAIRMAN & CEOMar 03, 2022 Option Exercise$23.6112,643298,5011,095,152Mar 07, 2022, 05:34 PM
Gordon Joseph FPres&Co-Head Bausch&Lomb/Int'lMar 03, 2022 Option Exercise$23.614,07496,18797,028Mar 07, 2022, 05:32 PM
APPIO THOMASCEO, Pharma BusinessMar 03, 2022 Option Exercise$23.615,564131,366475,267Mar 07, 2022, 05:30 PM
Gordon Joseph FPres&Co-Head Bausch&Lomb/Int'lMar 02, 2022 Sale$23.3711,077258,869101,102Mar 04, 2022, 04:58 PM
Spurr RobertU.S. President-Pharma BusinessMar 02, 2022 Option Exercise$24.1735,627861,105101,021Mar 04, 2022, 04:09 PM
Spurr RobertU.S. President-Pharma BusinessMar 02, 2022 Sale$23.371,59537,27565,394Mar 04, 2022, 04:09 PM
PAPA JOSEPH CChairman & CEOFeb 28, 2022 Option Exercise$24.065,115123,0671,107,795Mar 02, 2022, 09:38 PM
PAPA JOSEPH CChairman & CEOFeb 26, 2022 Option Exercise$24.3513,183321,0061,126,116Mar 02, 2022, 09:38 PM
PAPA JOSEPH CChairman & CEOFeb 27, 2022 Option Exercise$24.35113,5572,765,1131,139,299Mar 02, 2022, 09:38 PM
Gordon Joseph FPres&Co-Head Bausch&Lomb/Int'lFeb 26, 2022 Option Exercise$24.351,52237,061120,233Mar 02, 2022, 09:29 PM
Gordon Joseph FPres&Co-Head Bausch&Lomb/Int'lFeb 27, 2022 Option Exercise$24.357,949193,558121,755Mar 02, 2022, 09:29 PM
Gordon Joseph FPres&Co-Head Bausch&Lomb/Int'lMar 01, 2022 Sale$23.826,338150,971112,179Mar 02, 2022, 09:29 PM
APPIO THOMASCEO, Pharma BusinessFeb 26, 2022 Option Exercise$24.352,19253,375330,543Mar 02, 2022, 09:12 PM
APPIO THOMASCEO, Pharma BusinessFeb 27, 2022 Option Exercise$24.3511,184272,330332,735Mar 02, 2022, 09:12 PM
Spurr RobertU.S. President-Pharma BusinessFeb 26, 2022 Option Exercise$24.351,62839,64268,640Mar 02, 2022, 09:08 PM
Spurr RobertU.S. President-Pharma BusinessFeb 27, 2022 Option Exercise$24.357,297177,68270,268Mar 02, 2022, 09:08 PM
ACKERMANN CHRISTINAEVP AND GENERAL COUNSELFeb 27, 2022 Option Exercise$24.3516,028390,282175,754Mar 02, 2022, 09:06 PM
Munsch FrederickSVP, Controller and CAOFeb 26, 2022 Option Exercise$24.353067,45124,124Mar 02, 2022, 09:01 PM
Munsch FrederickSVP, Controller and CAOFeb 27, 2022 Option Exercise$24.351,65240,22624,430Mar 02, 2022, 09:01 PM
Eldessouky SamEVP & Chief Financial OfficerFeb 26, 2022 Option Exercise$24.3581419,821121,615Mar 02, 2022, 09:00 PM
Eldessouky SamEVP & Chief Financial OfficerFeb 27, 2022 Option Exercise$24.354,02097,887122,429Mar 02, 2022, 09:00 PM
Spurr RobertU.S. President-Pharma BusinessFeb 15, 2022 Sale$25.023,25181,34060,299Feb 17, 2022, 04:36 PM
Spurr RobertU.S. President-Pharma BusinessJan 18, 2022 Sale$26.633,25186,57463,550Jan 20, 2022, 07:55 PM
DE SCHUTTER RICHARD UDirectorDec 31, 2021 Option Exercise$27.611,24534,374319,588Jan 03, 2022, 04:17 PM
WECHSLER AMY BDirectorDec 31, 2021 Option Exercise$27.612496,87599,054Jan 03, 2022, 04:16 PM
ROBERTSON RUSSEL CDirectorDec 31, 2021 Option Exercise$27.611,38038,102126,585Jan 03, 2022, 04:14 PM
Paulson JohnDirectorDec 31, 2021 Option Exercise$27.611,10930,61985,289Jan 03, 2022, 04:12 PM
Miller Steven DDirectorDec 31, 2021 Option Exercise$27.611,10930,61961,889Jan 03, 2022, 04:10 PM
ICAHN BRETTDirectorDec 31, 2021 Option Exercise$27.611,10930,61911,767Jan 03, 2022, 04:07 PM
APPIO THOMASCEO, Pharma BusinessDec 15, 2021 Option Exercise$24.493,46184,760317,225Dec 30, 2021, 07:29 PM
Miller Steven DDirectorNov 30, 2021 Buy$24.1710,000241,69910,000Dec 02, 2021, 07:15 PM
Miller Steven DDirectorNov 30, 2021 Buy$24.2450,0001,211,82560,780Dec 02, 2021, 07:15 PM
Spurr RobertU.S. President-Pharma BusinessOct 01, 2021 Option Exercise$28.602838,09466,801Oct 05, 2021, 04:36 PM
WECHSLER AMY BDirectorSep 30, 2021 Option Exercise$27.852466,85198,805Oct 04, 2021, 04:48 PM
ROBERTSON RUSSEL CDirectorSep 30, 2021 Option Exercise$27.851,36838,099125,205Oct 04, 2021, 04:47 PM
Paulson JohnDirectorSep 30, 2021 Option Exercise$27.851,09930,60784,180Oct 04, 2021, 04:46 PM
Miller Steven DDirectorSep 30, 2021 Option Exercise$27.851,09930,60710,780Oct 04, 2021, 04:44 PM
ICAHN BRETTDirectorSep 30, 2021 Option Exercise$27.851,09930,60710,658Oct 04, 2021, 04:42 PM
DE SCHUTTER RICHARD UDirectorSep 30, 2021 Option Exercise$27.851,23434,367318,343Oct 04, 2021, 04:41 PM
PAPA JOSEPH CCHAIRMAN & CEOSep 14, 2021 Option Exercise$28.665,010143,5871,031,419Sep 15, 2021, 05:15 PM
PAPA JOSEPH CCHAIRMAN & CEOSep 13, 2021 Option Exercise$29.193,549103,5951,036,429Sep 15, 2021, 05:15 PM
Spurr RobertPresident, SalixAug 27, 2021 Option Exercise$28.951,27836,99858,058Aug 31, 2021, 04:09 PM
ACKERMANN CHRISTINAEVP AND GENERAL COUNSELAug 27, 2021 Option Exercise$28.955,017145,242161,741Aug 31, 2021, 04:07 PM
VON ESCHENBACH ANDREW C.DirectorAug 05, 2021 Buy$25.941,40036,31638,647Aug 09, 2021, 04:13 PM
DE SCHUTTER RICHARD UDirectorAug 04, 2021 Buy$25.0110,000250,123317,109Aug 06, 2021, 04:24 PM
ROBERTSON RUSSEL CDirectorJun 30, 2021 Option Exercise$29.321,30038,116123,837Jul 02, 2021, 04:15 PM
Miller Steven DDirectorJun 30, 2021 Option Exercise$29.321,04430,6109,681Jul 02, 2021, 04:11 PM
ICAHN BRETTDirectorJun 30, 2021 Option Exercise$29.321,04430,6109,559Jul 02, 2021, 04:09 PM
DE SCHUTTER RICHARD UDirectorJun 30, 2021 Option Exercise$29.321,17234,363307,109Jul 02, 2021, 04:06 PM
WECHSLER AMY BDirectorMar 31, 2021 Option Exercise$31.742166,856101,717Apr 02, 2021, 05:20 PM
Paulson JohnDirectorMar 31, 2021 Option Exercise$31.7495230,21674,392Apr 02, 2021, 05:14 PM
Miller Steven DDirectorMar 31, 2021 Option Exercise$31.741484,698992Apr 02, 2021, 05:11 PM
ICAHN BRETTDirectorMar 31, 2021 Option Exercise$31.741263,999870Apr 02, 2021, 05:09 PM
DE SCHUTTER RICHARD UDirectorMar 31, 2021 Option Exercise$31.741,07033,962298,292Apr 02, 2021, 05:06 PM
ACKERMANN CHRISTINAEVP AND GENERAL COUNSELMar 11, 2021 Option Exercise$32.8279626,125166,758Mar 15, 2021, 04:08 PM
PAPA JOSEPH CCHAIRMAN & CEOMar 10, 2021 Option Exercise$32.97231,1887,622,2691,039,978Mar 10, 2021, 09:01 PM
Herendeen PaulEVP and CFOMar 10, 2021 Option Exercise$32.9759,5191,962,342386,618Mar 10, 2021, 08:59 PM
Gordon Joseph FPres&Co-Head Bausch&Lomb/Int'lMar 10, 2021 Option Exercise$32.9712,461410,839110,638Mar 10, 2021, 08:55 PM
Eldessouky SamSVP, CHIEF ACCOUNTING OFFICERMar 10, 2021 Option Exercise$32.977,361242,692100,184Mar 10, 2021, 08:51 PM
APPIO THOMASPres&Co-Head Bausch&Lomb/Int'lMar 10, 2021 Option Exercise$32.9717,480576,316230,426Mar 10, 2021, 08:49 PM
ACKERMANN CHRISTINAEVP AND GENERAL COUNSELMar 10, 2021 Option Exercise$32.9721,960724,021167,554Mar 10, 2021, 08:46 PM
Spurr RobertPresident, SalixMar 01, 2021 Option Exercise$31.423,252102,17835,444Mar 03, 2021, 04:50 PM
PAPA JOSEPH CCHAIRMAN & CEOMar 01, 2021 Option Exercise$31.4228,192885,793771,673Mar 03, 2021, 04:47 PM
Herendeen PaulEVP and CFOMar 01, 2021 Option Exercise$31.4215,755495,022282,856Mar 03, 2021, 04:44 PM
Gordon Joseph FPres&Co-Head Bausch&Lomb/Int'lMar 01, 2021 Option Exercise$31.423,313104,09476,250Mar 03, 2021, 04:43 PM
Eldessouky SamSVP, CHIEF ACCOUNTING OFFICERMar 01, 2021 Option Exercise$31.421,73954,63979,313Mar 03, 2021, 04:33 PM
APPIO THOMASPres&Co-Head Bausch&Lomb/Int'lMar 01, 2021 Option Exercise$31.425,436170,799177,975Mar 03, 2021, 04:30 PM
ACKERMANN CHRISTINAEVP AND GENERAL COUNSELMar 01, 2021 Option Exercise$31.425,367168,631118,829Mar 03, 2021, 04:26 PM
WECHSLER AMY BDirectorDec 31, 2020 Option Exercise$20.803306,864101,501Jan 04, 2021, 06:59 PM
ROBERTSON RUSSEL CDirectorDec 31, 2020 Option Exercise$20.801,80237,482113,704Jan 04, 2021, 06:58 PM
Paulson JohnDirectorDec 31, 2020 Option Exercise$20.801,44229,99473,440Jan 04, 2021, 06:56 PM
DE SCHUTTER RICHARD UDirectorDec 31, 2020 Option Exercise$20.801,62233,738297,222Jan 04, 2021, 06:54 PM
APPIO THOMASPres&Co-Head Bausch&Lomb/Int'lDec 15, 2020 Option Exercise$20.613,22466,447183,411Dec 17, 2020, 07:29 PM
Humphries William D.President, Ortho-DermatologicsDec 04, 2020 Option Exercise$14.38114,0551,640,111349,090Dec 08, 2020, 04:23 PM
Humphries William D.President, Ortho-DermatologicsDec 04, 2020 Sale$19.87114,0552,266,398235,035Dec 08, 2020, 04:23 PM
Humphries William D.President, Ortho-DermatologicsNov 24, 2020 Option Exercise$14.3821,658311,442258,176Nov 30, 2020, 04:50 PM
Humphries William D.President, Ortho-DermatologicsNov 23, 2020 Option Exercise$14.381,48321,326236,518Nov 30, 2020, 04:50 PM
Humphries William D.President, Ortho-DermatologicsNov 27, 2020 Option Exercise$14.3813,663196,474248,698Nov 30, 2020, 04:50 PM
Humphries William D.President, Ortho-DermatologicsNov 27, 2020 Sale$19.6313,663268,207235,035Nov 30, 2020, 04:50 PM
Humphries William D.President, Ortho-DermatologicsNov 24, 2020 Sale$19.6321,658425,196235,035Nov 30, 2020, 04:50 PM
Humphries William D.President, Ortho-DermatologicsNov 23, 2020 Sale$19.631,48329,115235,035Nov 30, 2020, 04:50 PM
Spurr RobertPresident, SalixOct 02, 2020 Option Exercise$15.892764,38638,696Oct 06, 2020, 04:50 PM
WECHSLER AMY BDirectorSep 30, 2020 Option Exercise$15.544426,869101,171Oct 02, 2020, 05:03 PM
ROBERTSON RUSSEL CDirectorSep 30, 2020 Option Exercise$15.542,41337,498111,902Oct 02, 2020, 05:03 PM
Paulson JohnDirectorSep 30, 2020 Option Exercise$15.541,93029,99271,998Oct 02, 2020, 05:02 PM
DE SCHUTTER RICHARD UDirectorSep 30, 2020 Option Exercise$15.542,17133,737295,600Oct 02, 2020, 05:01 PM
PAPA JOSEPH CCHAIRMAN & CEOSep 15, 2020 Option Exercise$15.915,11581,380799,865Sep 16, 2020, 04:09 PM
PAPA JOSEPH CCHAIRMAN & CEOSep 14, 2020 Option Exercise$15.403,62355,794804,980Sep 16, 2020, 04:09 PM
Herendeen PaulEVP and CFOSep 15, 2020 Option Exercise$15.911,64226,124298,611Sep 16, 2020, 04:06 PM
Humphries William D.President, Ortho-DermatologicsSep 08, 2020 Sale$16.175,66791,635235,035Sep 10, 2020, 04:34 PM
Spurr RobertPresident, SalixAug 28, 2020 Option Exercise$17.001,27821,72638,972Aug 31, 2020, 06:50 PM
Humphries William D.President, Ortho-DermatologicsAug 17, 2020 Option Exercise$17.484,56779,831240,702Aug 19, 2020, 07:12 PM
ROBERTSON RUSSEL CDirectorJun 30, 2020 Option Exercise$18.292,05037,495109,489Jul 02, 2020, 04:35 PM
Paulson JohnDirectorJun 30, 2020 Option Exercise$18.291,54528,25870,068Jul 02, 2020, 04:30 PM
DE SCHUTTER RICHARD UDirectorJun 30, 2020 Option Exercise$18.291,75032,008293,429Jul 02, 2020, 04:25 PM
WECHSLER AMY BDirectorJun 30, 2020 Option Exercise$18.293756,859100,729Jul 02, 2020, 12:00 AM
ValueAct Holdings, L.P.DirectorJun 05, 2020 Buy$19.24948,35318,246,31217,931,594Jun 09, 2020, 08:24 PM
ValueAct Holdings, L.P.DirectorJun 05, 2020 Sale$19.24948,35318,246,3120Jun 09, 2020, 08:24 PM
Paulson JohnDirectorMay 13, 2020 Buy$16.521,330,04421,972,61724,210,115May 14, 2020, 06:25 PM
Paulson JohnDirectorMay 12, 2020 Buy$17.352,041,03635,421,08122,880,071May 14, 2020, 06:25 PM
Paulson JohnDirectorMay 14, 2020 Buy$15.871,628,92025,857,83725,839,035May 14, 2020, 06:25 PM
PAPA JOSEPH CCHAIRMAN & CEOMay 04, 2020 Option Exercise$17.1695,4891,638,591808,603May 06, 2020, 04:02 PM
Hale David RobertDirectorApr 29, 2020 Option Exercise$18.1162411,30110,009May 01, 2020, 05:37 PM
DE SCHUTTER RICHARD UDirectorApr 29, 2020 Option Exercise$18.1162411,301280,642May 01, 2020, 04:11 PM
WECHSLER AMY BDirectorMar 31, 2020 Option Exercise$15.504436,86789,317Apr 02, 2020, 04:32 PM
ROBERTSON RUSSEL CDirectorMar 31, 2020 Option Exercise$15.502,41937,49596,402Apr 02, 2020, 04:30 PM
Paulson JohnDirectorMar 31, 2020 Option Exercise$15.501,77427,49757,486Apr 02, 2020, 04:26 PM
DE SCHUTTER RICHARD UDirectorMar 31, 2020 Option Exercise$15.502,01631,248281,266Apr 02, 2020, 04:24 PM
Ross Thomas W. Sr.DirectorMar 12, 2020 Buy$15.532,50038,83779,242Mar 16, 2020, 04:24 PM
PAPA JOSEPH CCHAIRMAN & CEOMar 09, 2020 Option Exercise$20.9618,488387,508904,092Mar 11, 2020, 09:03 PM
Herendeen PaulEVP and CFOMar 09, 2020 Option Exercise$20.969,328195,515300,253Mar 11, 2020, 09:01 PM
Gordon Joseph FPres&Co-Head Bausch&Lomb/Int'lMar 09, 2020 Option Exercise$20.962,23946,92979,563Mar 11, 2020, 08:59 PM
Eldessouky SamSVP, CHIEF ACCOUNTING OFFICERMar 09, 2020 Option Exercise$20.961,74936,65981,052Mar 11, 2020, 08:55 PM
APPIO THOMASPres&Co-Head Bausch&Lomb/Int'lMar 09, 2020 Option Exercise$20.962,73457,305186,635Mar 11, 2020, 08:54 PM
ACKERMANN CHRISTINAEVP AND GENERAL COUNSELMar 09, 2020 Option Exercise$20.963,34370,06987,245Mar 11, 2020, 08:52 PM
ACKERMANN CHRISTINAEVP AND GENERAL COUNSELMar 10, 2020 Buy$18.254,39080,10691,635Mar 11, 2020, 08:52 PM
VON ESCHENBACH ANDREW C.DirectorMar 10, 2020 Buy$18.181,10019,99618,565Mar 11, 2020, 08:50 PM
DE SCHUTTER RICHARD UDirectorMar 03, 2020 Buy$23.085,000115,415279,250Mar 11, 2020, 08:47 PM
DE SCHUTTER RICHARD UDirectorMar 10, 2020 Buy$18.263,80069,37713,800Mar 11, 2020, 08:47 PM
PAPA JOSEPH CCHAIRMAN & CEOMar 02, 2020 Option Exercise$22.524,925110,911922,580Mar 03, 2020, 05:28 PM
PAPA JOSEPH CCHAIRMAN & CEOFeb 28, 2020 Option Exercise$24.449,269226,534927,505Mar 03, 2020, 05:28 PM
Humphries William D.President, Ortho-DermatologicsFeb 28, 2020 Option Exercise$24.442,26455,332245,269Mar 03, 2020, 05:26 PM
Herendeen PaulEVP and CFOFeb 28, 2020 Option Exercise$24.447,167175,161309,581Mar 03, 2020, 05:24 PM
Gordon Joseph FPres&Co-Head Bausch&Lomb/Int'lFeb 28, 2020 Option Exercise$24.442,49961,07681,802Mar 03, 2020, 05:22 PM
Eldessouky SamSVP, CHIEF ACCOUNTING OFFICERFeb 28, 2020 Option Exercise$24.4486921,23882,801Mar 03, 2020, 05:20 PM
APPIO THOMASPres&Co-Head Bausch&Lomb/Int'lFeb 28, 2020 Option Exercise$24.442,79668,334189,369Mar 03, 2020, 04:54 PM
ACKERMANN CHRISTINAEVP AND GENERAL COUNSELFeb 28, 2020 Option Exercise$24.443,77992,35990,588Mar 03, 2020, 04:52 PM
Humphries William D.President, Ortho-DermatologicsFeb 20, 2020 Option Exercise$26.4656,5321,495,837234,027Feb 24, 2020, 08:54 PM
Gordon Joseph FPres&Co-Head Bausch&Lomb/Int'lFeb 20, 2020 Option Exercise$26.4611,703309,66170,795Feb 21, 2020, 09:58 PM
Eldessouky SamSVP, CHIEF ACCOUNTING OFFICERFeb 20, 2020 Option Exercise$26.468,943236,63276,917Feb 21, 2020, 09:56 PM
APPIO THOMASPres&Co-Head Bausch&Lomb/Int'lFeb 20, 2020 Option Exercise$26.469,866261,054172,716Feb 21, 2020, 09:54 PM
ACKERMANN CHRISTINAEVP AND GENERAL COUNSELFeb 20, 2020 Option Exercise$26.4622,378592,12259,190Feb 21, 2020, 09:52 PM
Gordon Joseph FPres&Co-Head Bausch&Lomb/Int'lJan 07, 2020 Option Exercise$29.422,11862,31249,078Jan 09, 2020, 04:24 PM
Eldessouky SamSVP, CHIEF ACCOUNTING OFFICERJan 07, 2020 Option Exercise$29.421,69449,83759,750Jan 09, 2020, 04:21 PM
APPIO THOMASPres&Co-Head Bausch&Lomb/Int'lJan 07, 2020 Option Exercise$29.421,82753,750157,517Jan 09, 2020, 04:19 PM
ACKERMANN CHRISTINAEVP AND GENERAL COUNSELJan 07, 2020 Option Exercise$29.423,36098,85147,165Jan 09, 2020, 04:17 PM
Humphries William D.President, Ortho-DermatologicsJan 03, 2020 Option Exercise$29.9214,559435,605163,865Jan 07, 2020, 04:18 PM
WECHSLER AMY BDirectorDec 31, 2019 Option Exercise$29.921,06531,86588,874Jan 02, 2020, 04:49 PM
ROBERTSON RUSSEL CDirectorDec 31, 2019 Option Exercise$29.921,25337,49093,983Jan 02, 2020, 04:47 PM
Paulson JohnDirectorDec 31, 2019 Option Exercise$29.9291927,49655,712Jan 02, 2020, 04:34 PM
DE SCHUTTER RICHARD UDirectorDec 31, 2019 Option Exercise$29.921,04431,236274,250Jan 02, 2020, 04:29 PM
APPIO THOMASPres&Co-Head Bausch&Lomb/Int'lDec 16, 2019 Option Exercise$31.003,337103,447159,344Dec 17, 2019, 07:20 PM
WECHSLER AMY BDirectorSep 30, 2019 Option Exercise$21.851,45831,85787,809Oct 02, 2019, 05:43 PM
ROBERTSON RUSSEL CDirectorSep 30, 2019 Option Exercise$21.851,71637,49592,730Oct 02, 2019, 05:41 PM
Paulson JohnDirectorSep 30, 2019 Option Exercise$21.851,25827,48754,793Oct 02, 2019, 05:39 PM
DE SCHUTTER RICHARD UDirectorSep 30, 2019 Option Exercise$21.851,43031,246273,206Oct 02, 2019, 05:33 PM
PAPA JOSEPH CCHAIRMAN & CEOSep 16, 2019 Option Exercise$23.245,115118,873855,734Sep 18, 2019, 05:08 PM
Herendeen PaulEVP and CFOSep 16, 2019 Option Exercise$23.241,64238,160253,718Sep 18, 2019, 05:05 PM
PAPA JOSEPH CCHAIRMAN & CEOSep 13, 2019 Buy$23.3130,000699,300839,601Sep 13, 2019, 09:06 PM
Herendeen PaulEVP and CFOAug 23, 2019 Option Exercise$22.4024,625551,600255,360Aug 27, 2019, 04:07 PM
APPIO THOMASPres&Co-Head Bausch&Lomb/Int'lAug 19, 2019 Option Exercise$21.308,362178,111162,681Aug 21, 2019, 04:19 PM
McKenna Mark C.President, SalixAug 19, 2019 Sale$21.8310,773235,22120,756Aug 21, 2019, 04:15 PM
Humphries William D.President, Ortho-DermatologicsAug 16, 2019 Buy$21.1830,703650,142147,721Aug 20, 2019, 04:17 PM
ACKERMANN CHRISTINAEVP AND GENERAL COUNSELAug 09, 2019 Option Exercise$22.397,779174,17253,943Aug 13, 2019, 04:03 PM
ACKERMANN CHRISTINAEVP AND GENERAL COUNSELAug 12, 2019 Sale$22.453,41876,72650,525Aug 13, 2019, 04:03 PM
ACKERMANN CHRISTINAEVP AND GENERAL COUNSELJul 11, 2019 Sale$24.813,96898,44661,722Jul 15, 2019, 04:30 PM
WECHSLER AMY BDirectorJun 28, 2019 Option Exercise$25.221,26331,85386,351Jul 02, 2019, 04:22 PM
ROBERTSON RUSSEL CDirectorJun 28, 2019 Option Exercise$25.221,48637,47791,014Jul 02, 2019, 04:15 PM
DE SCHUTTER RICHARD UDirectorJun 28, 2019 Option Exercise$25.221,23931,248271,776Jul 02, 2019, 04:11 PM
Paulson JohnDirectorJun 28, 2019 Option Exercise$25.221,09027,49053,535Jul 02, 2019, 12:00 AM
McKenna Mark C.President, SalixJun 24, 2019 Option Exercise$23.821,91345,56831,529Jun 26, 2019, 04:17 PM
Eldessouky SamSVP, CHIEF ACCOUNTING OFFICERJun 04, 2019 Option Exercise$20.736,370132,05061,444Jun 06, 2019, 04:14 PM
Gordon Joseph FPres&Co-Head Bausch&Lomb/Int'lMay 06, 2019 Option Exercise$23.5169316,29251,196May 08, 2019, 04:25 PM
McKenna Mark C.President, SalixMay 06, 2019 Option Exercise$23.5174617,53833,442May 08, 2019, 04:16 PM
Hale David RobertDirectorMay 03, 2019 Option Exercise$23.5110,633249,98220,518May 03, 2019, 05:46 PM
Hale David RobertDirectorMay 01, 2019 Option Exercise$23.633,99694,4259,885May 03, 2019, 05:46 PM
WECHSLER AMY BDirectorMay 03, 2019 Option Exercise$23.5110,633249,98285,088May 03, 2019, 04:21 PM
VON ESCHENBACH ANDREW C.DirectorMay 03, 2019 Option Exercise$23.5110,633249,98217,465May 03, 2019, 04:20 PM
Ross Thomas W. Sr.DirectorMay 03, 2019 Option Exercise$23.5110,633249,98276,802May 03, 2019, 04:19 PM
ROBERTSON RUSSEL CDirectorMay 03, 2019 Option Exercise$23.5110,633249,98289,528May 03, 2019, 04:18 PM
POWER ROBERT NDirectorMay 03, 2019 Option Exercise$23.5110,633249,98282,742May 03, 2019, 04:17 PM
Paulson JohnDirectorMay 03, 2019 Option Exercise$23.5110,633249,98252,445May 03, 2019, 04:16 PM
KAVANAGH SARAH BDirectorMay 03, 2019 Option Exercise$23.5110,633249,98264,378May 03, 2019, 04:15 PM
KARABELAS ARGERIS NDirectorMay 03, 2019 Option Exercise$23.5110,633249,98270,646May 03, 2019, 04:14 PM
DE SCHUTTER RICHARD UDirectorMay 03, 2019 Option Exercise$23.5110,633249,982270,537May 03, 2019, 04:13 PM
DE SCHUTTER RICHARD UDirectorMay 01, 2019 Option Exercise$23.633,99694,425259,904May 03, 2019, 04:13 PM
WECHSLER AMY BDirectorMar 29, 2019 Option Exercise$24.701,29031,86374,455Apr 03, 2019, 05:08 PM
ROBERTSON RUSSEL CDirectorMar 29, 2019 Option Exercise$24.701,51837,49578,895Apr 03, 2019, 05:04 PM
Paulson JohnDirectorMar 29, 2019 Option Exercise$24.701,11327,49141,812Apr 03, 2019, 04:55 PM
DE SCHUTTER RICHARD UDirectorMar 29, 2019 Option Exercise$24.701,26531,246263,900Apr 03, 2019, 04:47 PM
PAPA JOSEPH CCHAIRMAN & CEOMar 08, 2019 Option Exercise$23.5618,658439,582809,601Mar 12, 2019, 04:40 PM
McKenna Mark C.President, SalixMar 08, 2019 Option Exercise$23.5697422,94734,188Mar 12, 2019, 04:38 PM
Herendeen PaulEVP and CFOMar 08, 2019 Option Exercise$23.569,796230,794279,985Mar 12, 2019, 04:31 PM
Gordon Joseph FPres&Co-Head Bausch&Lomb/Int'lMar 08, 2019 Option Exercise$23.561,55736,68351,889Mar 12, 2019, 04:28 PM
Eldessouky SamSVP, CHIEF ACCOUNTING OFFICERMar 08, 2019 Option Exercise$23.561,21728,67367,814Mar 12, 2019, 04:27 PM
APPIO THOMASPres&Co-Head Bausch&Lomb/Int'lMar 08, 2019 Option Exercise$23.562,90768,489171,043Mar 12, 2019, 04:25 PM
ACKERMANN CHRISTINAEVP AND GENERAL COUNSELMar 08, 2019 Option Exercise$23.563,63085,52365,690Mar 12, 2019, 04:17 PM
PAPA JOSEPH CCHAIRMAN & CEOFeb 28, 2019 Buy$23.6730,000710,100717,077Feb 28, 2019, 04:10 PM
McKenna Mark C.President, SalixJan 08, 2019 Option Exercise$21.251,19025,28819,941Jan 10, 2019, 04:11 PM
Gordon Joseph FPres&Co-Head Bausch&Lomb/Int'lJan 08, 2019 Option Exercise$21.252,16946,09138,225Jan 10, 2019, 04:10 PM
Eldessouky SamSVP, CHIEF ACCOUNTING OFFICERJan 08, 2019 Option Exercise$21.251,69636,04061,421Jan 10, 2019, 04:09 PM
APPIO THOMASPres&Co-Head Bausch&Lomb/Int'lJan 08, 2019 Option Exercise$21.251,72236,593152,640Jan 10, 2019, 04:04 PM
ACKERMANN CHRISTINAEVP AND GENERAL COUNSELJan 08, 2019 Option Exercise$21.253,44673,22848,010Jan 10, 2019, 04:02 PM
Humphries William D.President, Ortho-DermatologicsJan 03, 2019 Option Exercise$18.4713,311245,854101,797Jan 07, 2019, 04:22 PM
ROBERTSON RUSSEL CDirectorDec 31, 2018 Option Exercise$18.472,21040,81977,377Jan 03, 2019, 04:31 PM
Paulson JohnDirectorDec 31, 2018 Option Exercise$18.471,48827,48340,699Jan 03, 2019, 04:27 PM
WECHSLER AMY BDirectorDec 31, 2018 Option Exercise$18.471,71631,69573,165Jan 03, 2019, 12:00 AM
DE SCHUTTER RICHARD UDirectorDec 31, 2018 Option Exercise$18.471,69131,233262,635Jan 03, 2019, 12:00 AM
APPIO THOMASPres&Co-Head Bausch&Lomb/Int'lDec 14, 2018 Buy$22.9625,440584,018128,922Dec 18, 2018, 04:22 PM
ACKERMANN CHRISTINAEVP AND GENERAL COUNSELOct 16, 2018 Sale$25.504,542115,82151,456Oct 17, 2018, 04:15 PM
ACKERMANN CHRISTINAEVP AND GENERAL COUNSELOct 15, 2018 Sale$24.8315,404382,48155,998Oct 17, 2018, 04:15 PM
WECHSLER AMY BDirectorSep 28, 2018 Option Exercise$25.671,21731,24071,449Oct 02, 2018, 04:38 PM
DE SCHUTTER RICHARD UDirectorSep 28, 2018 Option Exercise$25.671,21731,240260,944Oct 02, 2018, 12:00 AM
Paulson JohnDirectorSep 28, 2018 Option Exercise$25.671,07127,49339,211Oct 02, 2018, 12:00 AM
ROBERTSON RUSSEL CDirectorSep 28, 2018 Option Exercise$25.671,46037,47875,167Oct 02, 2018, 12:00 AM
APPIO THOMASPres&Co-Head Bausch&Lomb/Int'lAug 20, 2018 Option Exercise$21.696,604143,241103,482Sep 18, 2018, 04:31 PM
DE SCHUTTER RICHARD UDirectorSep 13, 2018 Buy$23.96125,0002,995,000259,727Sep 17, 2018, 03:00 PM
Herendeen PaulEVP and CFOSep 14, 2018 Buy$22.6110,000226,100216,866Sep 17, 2018, 02:58 PM
PAPA JOSEPH CCHAIRMAN & CEOSep 14, 2018 Buy$22.3230,000669,600657,077Sep 17, 2018, 02:56 PM
Herendeen PaulEVP and CFOAug 23, 2018 Option Exercise$22.3724,626550,884206,866Aug 27, 2018, 07:32 PM
APPIO THOMASPres&Co-Head Bausch&Lomb/Int'lAug 20, 2018 Option Exercise$21.695,501119,317104,585Aug 22, 2018, 04:30 PM
ACKERMANN CHRISTINAEVP AND GENERAL COUNSELAug 09, 2018 Option Exercise$23.527,779182,96271,402Aug 13, 2018, 05:04 PM
DE SCHUTTER RICHARD UDirectorJun 29, 2018 Option Exercise$23.241,34431,235134,727Jul 03, 2018, 04:49 PM
DE SCHUTTER RICHARD UDirectorMay 15, 2018 Buy$21.8010,000218,00010,000Jul 03, 2018, 04:49 PM
Paulson JohnDirectorJun 29, 2018 Option Exercise$23.241,18327,49338,140Jul 03, 2018, 04:41 PM
ROBERTSON RUSSEL CDirectorJun 29, 2018 Option Exercise$23.241,61337,48673,707Jul 03, 2018, 04:36 PM
WECHSLER AMY BDirectorJun 29, 2018 Option Exercise$23.241,34431,23570,232Jul 03, 2018, 04:31 PM
Eldessouky SamSVP, CHIEF ACCOUNTING OFFICERJun 04, 2018 Option Exercise$22.086,142135,61563,117Jun 06, 2018, 05:15 PM
DE SCHUTTER RICHARD UDirectorMay 15, 2018 Buy$21.8315,000327,450133,383May 17, 2018, 04:43 PM
PAPA JOSEPH CCHAIRMAN & CEOMay 03, 2018 Option Exercise$18.3191,9421,683,458627,077May 04, 2018, 05:55 PM
Hale David RobertDirectorMay 01, 2018 Option Exercise$18.073,79468,55821,612May 03, 2018, 05:21 PM
DE SCHUTTER RICHARD UDirectorMay 01, 2018 Option Exercise$18.073,52263,643104,502May 03, 2018, 04:42 PM
WECHSLER AMY BDirectorMar 30, 2018 Option Exercise$15.921,96231,23555,007Apr 03, 2018, 05:03 PM
ROBERTSON RUSSEL CDirectorMar 30, 2018 Option Exercise$15.922,35537,49258,213Apr 03, 2018, 12:00 AM
DE SCHUTTER RICHARD UDirectorMar 30, 2018 Option Exercise$15.921,96231,235108,024Apr 03, 2018, 12:00 AM
Paulson JohnDirectorMar 30, 2018 Option Exercise$15.921,72727,49423,076Apr 03, 2018, 12:00 AM
Herendeen PaulEVP and CFOMar 13, 2018 Buy$16.1015,000241,470231,492Mar 13, 2018, 04:43 PM
PAPA JOSEPH CCHAIRMAN & CEOMar 13, 2018 Buy$16.0530,000481,500719,019Mar 13, 2018, 04:38 PM
DE SCHUTTER RICHARD UDirectorMar 08, 2018 Buy$15.3410,000153,400106,062Mar 12, 2018, 08:59 PM
Paulson JohnDirectorMar 06, 2018 Buy$15.407,066,629108,826,08420,839,035Mar 08, 2018, 05:04 PM
Paulson JohnDirectorMar 06, 2018 Sale$15.407,066,629108,826,08413,772,406Mar 08, 2018, 05:04 PM
APPIO THOMASEVP, COMPANY GROUP CHAIRMANJan 08, 2018 Option Exercise$23.851,26430,14687,924Jan 29, 2018, 10:32 AM
Eldessouky SamSVP, CHIEF ACCOUNTING OFFICERJan 08, 2018 Option Exercise$23.851,82643,55058,605Jan 09, 2018, 03:30 PM
APPIO THOMASEVP, COMPANY GROUP CHAIRMANJan 08, 2018 Option Exercise$23.851,55737,13487,631Jan 09, 2018, 03:27 PM
ACKERMANN CHRISTINAEVP AND GENERAL COUNSELJan 08, 2018 Option Exercise$23.853,64987,02958,724Jan 09, 2018, 03:25 PM
Humphries William D.EVP, COMPANY GROUP CHAIRMANJan 03, 2018 Option Exercise$20.7814,730306,089115,108Jan 05, 2018, 03:58 PM
Paulson JohnDirectorDec 29, 2017 Option Exercise$20.781,32327,49221,349Jan 03, 2018, 06:00 PM
ROBERTSON RUSSEL CDirectorDec 29, 2017 Option Exercise$20.781,80437,48755,858Jan 03, 2018, 11:19 AM
DE SCHUTTER RICHARD UDirectorDec 29, 2017 Option Exercise$20.781,50331,23296,062Jan 03, 2018, 10:21 AM
WECHSLER AMY BDirectorDec 29, 2017 Option Exercise$20.781,50331,23253,045Jan 03, 2018, 10:13 AM
DE SCHUTTER RICHARD UDirectorNov 17, 2017 Buy$14.3310,000143,30094,559Nov 21, 2017, 06:26 PM
Paulson JohnDirectorNov 16, 2017 Buy$14.40344,2164,955,50621,183,251Nov 20, 2017, 06:00 PM
Paulson JohnDirectorNov 16, 2017 Sale$14.39344,2164,952,82120,839,035Nov 20, 2017, 06:00 PM
Paulson JohnDirectorSep 29, 2017 Option Exercise$14.331,86026,65420,026Oct 04, 2017, 05:58 PM
WECHSLER AMY BDirectorSep 29, 2017 Option Exercise$14.332,18031,23951,542Oct 03, 2017, 05:45 PM
ROBERTSON RUSSEL CDirectorSep 29, 2017 Option Exercise$14.332,61637,48754,054Oct 03, 2017, 05:44 PM
DE SCHUTTER RICHARD UDirectorSep 29, 2017 Option Exercise$14.332,18031,23984,559Oct 03, 2017, 05:41 PM
Herendeen PaulEVP and CFOAug 23, 2017 Option Exercise$14.1417,175242,855156,825Aug 25, 2017, 04:30 PM
DE SCHUTTER RICHARD UDirectorAug 21, 2017 Buy$14.3310,000143,29682,379Aug 22, 2017, 04:39 PM
APPIO THOMASEVP, COMPANY GROUP CHAIRMANAug 18, 2017 Option Exercise$14.155,68780,47189,188Aug 22, 2017, 04:37 PM
ACKERMANN CHRISTINAEVP AND GENERAL COUNSELAug 09, 2017 Option Exercise$15.376,04692,92762,373Aug 11, 2017, 04:41 PM
Paulson JohnDirectorAug 09, 2017 Option Exercise$14.66974,36514,283,70420,839,035Aug 10, 2017, 06:36 PM
ROBERTSON RUSSEL CDirectorJun 30, 2017 Option Exercise$17.302,16737,48951,438Jul 05, 2017, 06:05 PM
WECHSLER AMY BDirectorJun 30, 2017 Option Exercise$17.301,80631,24449,362Jul 05, 2017, 06:04 PM
DE SCHUTTER RICHARD UDirectorJun 30, 2017 Option Exercise$17.301,80731,26172,379Jul 05, 2017, 04:36 PM
Eldessouky SamSVP, CHIEF ACCOUNTING OFFICERJun 07, 2017 Option Exercise$12.516,15977,04960,431Jun 09, 2017, 04:45 PM
DE SCHUTTER RICHARD UDirectorMay 11, 2017 Buy$13.9020,000278,00070,572May 15, 2017, 05:19 PM
APPIO THOMASEVP, COMPANY GROUP CHAIRMANMay 10, 2017 Option Exercise$9.713,27431,79194,875May 11, 2017, 04:56 PM
DE SCHUTTER RICHARD UDirectorMay 08, 2017 Option Exercise$9.662,14820,75050,572May 08, 2017, 04:52 PM
Hale David RobertDirectorMay 03, 2017 Option Exercise$9.663,92337,89612,803May 05, 2017, 06:39 PM
ESHELMAN FREDRIC NDirectorMay 03, 2017 Option Exercise$9.664,90447,37312,892May 05, 2017, 04:53 PM
WECHSLER AMY BDirectorMar 31, 2017 Option Exercise$11.032,46027,13422,150Apr 04, 2017, 06:09 PM
ROBERTSON RUSSEL CDirectorMar 31, 2017 Option Exercise$11.033,12734,49123,865Apr 04, 2017, 06:02 PM
INGRAM ROBERT ALEXANDERDirectorMar 31, 2017 Option Exercise$11.032,12023,38492,046Apr 04, 2017, 05:53 PM
DE SCHUTTER RICHARD UDirectorMar 31, 2017 Option Exercise$11.032,12423,42827,314Apr 04, 2017, 05:47 PM
DE SCHUTTER RICHARD UDirectorMar 15, 2017 Buy$10.8010,000108,00025,190Mar 16, 2017, 05:12 PM
Herendeen PaulEVP and CFOMar 14, 2017 Buy$10.7224,000257,280174,000Mar 16, 2017, 05:04 PM
ValueAct Holdings, L.P.DirectorMar 14, 2017 Buy$10.823,000,00032,465,00116,937,431Mar 16, 2017, 04:31 PM
Pershing Square Capital Management, L.P.DirectorMar 13, 2017 Sale$11.0018,114,432199,258,7520Mar 14, 2017, 04:14 PM
DE SCHUTTER RICHARD UDirectorJan 03, 2017 Option Exercise$15.2411,190170,53615,190Jan 04, 2017, 08:13 PM
WECHSLER AMY BDirectorDec 30, 2016 Option Exercise$14.521,72124,98919,690Jan 04, 2017, 07:59 PM
ROBERTSON RUSSEL CDirectorDec 30, 2016 Option Exercise$14.522,32433,74420,738Jan 04, 2017, 07:52 PM
INGRAM ROBERT ALEXANDERDirectorDec 30, 2016 Option Exercise$14.521,46321,24389,926Jan 04, 2017, 07:45 PM
Whitaker Anne ClemEVP, Company Group ChairmanDec 05, 2016 Option Exercise$18.006,012108,216158,544Dec 20, 2016, 06:26 PM
Whitaker Anne ClemEVP, Company Group ChairmanAug 02, 2016 Option Exercise$23.5483419,632158,544Dec 20, 2016, 06:04 PM
Ross Thomas W. Sr.DirectorDec 14, 2016 Buy$14.735,00073,65026,822Dec 16, 2016, 04:19 PM
Pershing Square Capital Management, L.P.DirectorDec 12, 2016 Sale$14.853,476,69051,628,84818,114,432Dec 13, 2016, 04:14 PM
Whitaker Anne ClemEVP, Company Group ChairmanDec 05, 2016 Option Exercise$18.006,505117,090158,885Dec 07, 2016, 04:52 PM
Kellen AriEVP, Company Group ChairmanDec 05, 2016 Option Exercise$18.0019,932358,776630,842Dec 07, 2016, 04:47 PM
Rosiello Robert L.EVP, Corp Dev & StrategyDec 05, 2016 Option Exercise$18.0014,687264,366517,683Dec 07, 2016, 04:40 PM
Rosiello Robert L.EVP, Corp Dev & StrategyNov 04, 2016 Option Exercise$22.0681718,023532,370Nov 08, 2016, 04:41 PM
INGRAM ROBERT ALEXANDERDirectorSep 30, 2016 Option Exercise$24.5586521,23688,463Oct 05, 2016, 04:07 PM
ROBERTSON RUSSEL CDirectorSep 30, 2016 Option Exercise$24.551,37633,78118,414Oct 04, 2016, 05:08 PM
WECHSLER AMY BDirectorSep 30, 2016 Option Exercise$24.551,01824,99217,969Oct 04, 2016, 04:59 PM
KARABELAS ARGERIS NDirectorAug 11, 2016 Buy$24.654,00098,60020,726Aug 12, 2016, 04:37 PM
Rosiello Robert L.EVP, Chief Financial OfficerAug 03, 2016 Option Exercise$23.541,33831,497533,187Aug 05, 2016, 04:44 PM
INGRAM ROBERT ALEXANDERDirectorJun 30, 2016 Option Exercise$20.141,08021,75187,598Jul 11, 2016, 06:38 PM
ROBERTSON RUSSEL CDirectorJun 30, 2016 Option Exercise$20.143126,28417,038Jul 11, 2016, 06:31 PM
WECHSLER AMY BDirectorJun 30, 2016 Option Exercise$20.142254,53116,951Jul 11, 2016, 06:22 PM
Hale David RobertDirectorJul 01, 2016 Option Exercise$23.783480917,840Jul 06, 2016, 07:56 PM
ESHELMAN FREDRIC NDirectorJul 01, 2016 Option Exercise$23.782661817,796Jul 06, 2016, 07:21 PM
Ross Thomas W. Sr.DirectorJun 13, 2016 Buy$24.404,00097,60021,882Jun 27, 2016, 03:40 PM
PAPA JOSEPH CCHAIRMAN & CEOJun 10, 2016 Buy$24.48202,0004,944,9602,442,199Jun 13, 2016, 06:47 AM
Schiller Howard BradleyChairman and CEOFeb 18, 2016 Option Exercise$91.4554,0914,946,622388,630Feb 22, 2016, 05:39 PM
Kellen AriEVP, Company Group ChairmanJan 26, 2016 Option Exercise$88.983,317295,147535,450Jan 28, 2016, 04:10 PM
Pearson J. MichaelChief Executive OfficerNov 05, 2015 Sale$78.481,297,399101,825,9732,665,009Nov 09, 2015, 05:24 PM
Farmer Ronald HaroldDirectorOct 21, 2015 Buy$181.601,500272,39515,532Oct 22, 2015, 05:09 PM
Farmer Ronald HaroldDirectorAug 26, 2015 Buy$220.00500110,0002,000Aug 27, 2015, 04:33 PM
Farmer Ronald HaroldDirectorAug 21, 2015 Buy$224.971,000224,9731,500Aug 25, 2015, 04:47 PM
Rosiello Robert L.EVP, Chief Financial OfficerJul 31, 2015 Buy$257.25704181,104441,675Aug 03, 2015, 04:54 PM
Rosiello Robert L.EVP, Chief Financial OfficerJul 30, 2015 Buy$253.997,1711,821,362440,971Aug 03, 2015, 04:54 PM
Rosiello Robert L.Executive Vice PresidentJun 12, 2015 Buy$232.5112,9002,999,37912,900Jun 16, 2015, 04:01 PM
UBBEN JEFFREY WDirectorJun 10, 2015 Sale$220.244,200,000925,011,61617,613,017Jun 12, 2015, 07:23 PM
Farmer Ronald HaroldDirectorJun 09, 2015 Buy$232.05500116,025500Jun 10, 2015, 05:02 PM
Farmer Ronald HaroldDirectorJun 08, 2015 Buy$289.20500144,60035,426Jun 10, 2015, 05:02 PM
Mirovsky PavelEVP, Pres. & GM Valeant EMENAJun 02, 2015 Option Exercise$51.0114,900760,04951,575Jun 03, 2015, 05:45 PM
Mirovsky PavelEVP, Pres. & GM Valeant EMENAJun 01, 2015 Option Exercise$51.011005,10136,775Jun 03, 2015, 05:45 PM
Mirovsky PavelEVP, Pres. & GM Valeant EMENAJun 02, 2015 Sale$238.0037,9009,020,31836,675Jun 03, 2015, 05:45 PM
Mirovsky PavelEVP, Pres. & GM Valeant EMENAJun 01, 2015 Sale$240.0010024,00036,675Jun 03, 2015, 05:45 PM
Whitaker Anne ClemDirectorMay 26, 2015 Buy$234.677,5001,760,0007,500May 27, 2015, 04:29 PM
Chai-Onn Robert RoswellEVP, CLO, General CounselMay 04, 2015 Option Exercise$25.4290,9382,311,644134,125May 06, 2015, 05:51 PM
Chai-Onn Robert RoswellEVP, CLO, General CounselMay 05, 2015 Option Exercise$6.1021,807133,02364,994May 06, 2015, 05:51 PM
Chai-Onn Robert RoswellEVP, CLO, General CounselMay 04, 2015 Sale$222.5490,93820,237,43343,187May 06, 2015, 05:51 PM
GOGGINS COLLEEN ADirectorMar 27, 2015 Option Exercise$198.1250099,0623,366Mar 31, 2015, 04:30 PM
Chai-Onn Robert RoswellEVP, CLO, General CounselMar 03, 2015 Option Exercise$6.1021,808133,02943,187Mar 04, 2015, 05:24 PM
Chai-Onn Robert RoswellEVP, CLO, General CounselMar 02, 2015 Option Exercise$25.4290,9392,311,669112,296Mar 04, 2015, 05:24 PM
Chai-Onn Robert RoswellEVP, CLO, General CounselMar 02, 2015 Sale$200.0190,93918,189,07421,379Mar 04, 2015, 05:24 PM
Farmer Ronald HaroldDirectorDec 12, 2014 Buy$160.4850080,24033,004Dec 16, 2014, 02:59 PM
UBBEN JEFFREY WDirectorDec 10, 2014 Buy$139.2950,0006,964,50018,030,936Dec 11, 2014, 06:59 PM
UBBEN JEFFREY WDirectorDec 09, 2014 Buy$140.25200,00028,050,00017,980,936Dec 11, 2014, 06:59 PM
STEVENSON KATHARINE BERGHUISDirectorDec 03, 2014 Buy$145.731,500218,59523,098Dec 03, 2014, 04:48 PM
Farmer Ronald HaroldDirectorNov 24, 2014 Buy$163.951,000163,95032,504Dec 01, 2014, 05:25 PM
UBBEN JEFFREY WDirectorNov 24, 2014 Buy$142.25210,00029,872,50017,780,936Nov 26, 2014, 04:11 PM
Chai-Onn Robert RoswellEVP, Gen. Couns. & Corp. Secy.Jun 23, 2014 Option Exercise$6.4510,20365,80934,202Jun 24, 2014, 04:37 PM
Chai-Onn Robert RoswellEVP, Gen. Couns. & Corp. Secy.Jun 23, 2014 Sale$121.7010,2031,241,67423,999Jun 24, 2014, 04:37 PM
Mirovsky PavelPresident of Valeant EuropeJun 02, 2014 Sale$131.2510,0001,312,4900Jun 04, 2014, 03:19 PM
Chai-Onn Robert RoswellEVP, Gen. Couns. & Corp. Secy.May 13, 2014 Option Exercise$6.4510,00064,50033,999May 14, 2014, 04:29 PM
Chai-Onn Robert RoswellEVP, Gen. Couns. & Corp. Secy.May 13, 2014 Sale$130.0810,0001,300,84023,999May 14, 2014, 04:29 PM
Weldon RyanEVP, Company Group ChairmanApr 28, 2014 Option Exercise$122.055,707696,539103,409Apr 30, 2014, 04:57 PM
Schiller Howard BradleyEVP, CFOApr 28, 2014 Option Exercise$122.054,849591,820263,000Apr 30, 2014, 04:42 PM
Kornwasser LaizerEVP, Company Group ChairmanApr 28, 2014 Option Exercise$122.0523,6792,890,02279,920Apr 30, 2014, 04:34 PM
Provencio Norma AnnDirectorApr 01, 2014 Sale$132.185,000660,885137,495Apr 02, 2014, 04:55 PM
Kornwasser LaizerEVP, Company Group ChairmanMar 21, 2014 Buy$134.972,481334,85853,582Mar 25, 2014, 01:06 PM
Chai-Onn Robert RoswellEVP, Gen. Couns. & Corp. Secy.Mar 17, 2014 Option Exercise$6.455,00032,25028,999Mar 19, 2014, 04:33 PM
Chai-Onn Robert RoswellEVP, Gen. Couns. & Corp. Secy.Mar 17, 2014 Sale$141.725,000708,60023,999Mar 19, 2014, 04:33 PM
Provencio Norma AnnDirectorMar 03, 2014 Sale$141.625,000708,075142,206Mar 05, 2014, 06:00 PM
Provencio Norma AnnDirectorFeb 03, 2014 Sale$136.235,000681,160147,206Feb 04, 2014, 06:15 PM
Kornwasser LaizerEVP, Company Group ChairmanJan 24, 2014 Buy$132.152,536335,12728,390Jan 28, 2014, 04:51 PM
Provencio Norma AnnDirectorJan 13, 2014 Sale$133.005,000664,995152,206Jan 14, 2014, 04:01 PM
Kornwasser LaizerEVP, Company Group ChairmanDec 30, 2013 Option Exercise$114.492,927335,09819,427Jan 02, 2014, 03:29 PM
Pearson J. MichaelChief Executive OfficerDec 14, 2013 Buy$81.41184,24714,999,5494,025,498Dec 17, 2013, 04:10 PM
Kornwasser LaizerEVP, Company Group ChairmanNov 18, 2013 Buy$107.383,500375,84416,500Nov 20, 2013, 04:27 PM
Farmer Ronald HaroldDirectorNov 06, 2013 Buy$107.981,500161,97027,808Nov 08, 2013, 04:07 PM
Provencio Norma AnnDirectorNov 01, 2013 Sale$106.705,000533,485158,647Nov 05, 2013, 05:03 PM
Kornwasser LaizerEVP, Company Group ChairmanSep 13, 2013 Buy$99.021,00099,0188,500Sep 17, 2013, 05:01 PM
Provencio Norma AnnDirectorSep 06, 2013 Sale$100.254,000401,000163,282Sep 11, 2013, 05:55 PM
Provencio Norma AnnDirectorSep 03, 2013 Sale$99.685,000498,400167,282Sep 04, 2013, 05:09 PM
Hassan FredDirectorAug 29, 2013 Buy$99.0151,0005,049,45953,969Sep 03, 2013, 05:17 PM
Farmer Ronald HaroldDirectorAug 27, 2013 Buy$102.952,000205,90025,557Aug 29, 2013, 04:46 PM
Farmer Ronald HaroldDirectorAug 28, 2013 Buy$99.9950049,99526,057Aug 29, 2013, 04:46 PM
Chai-Onn Robert RoswellEVP, GC and Corp. SecretaryAug 23, 2013 Buy$99.305,032499,673188,277Aug 23, 2013, 04:54 PM
Stolz Brian M.EVP, Administration and CHCOAug 12, 2013 Buy$100.714,500453,19932,156Aug 12, 2013, 06:10 PM
Kornwasser LaizerEVP, Company Group ChairmanAug 09, 2013 Buy$100.363,500351,2467,500Aug 12, 2013, 06:05 PM
Morfit G MasonDirectorJun 19, 2013 Buy$85.001,352,941114,999,9851,352,941Jun 21, 2013, 05:53 PM
Segal Lloyd MitchellDirectorJun 14, 2013 Buy$85.4514011,96321,174Jun 18, 2013, 04:23 PM
Segal Lloyd MitchellDirectorJun 11, 2013 Buy$86.4539033,717630Jun 13, 2013, 05:35 PM
Segal Lloyd MitchellDirectorJun 12, 2013 Buy$83.502,500208,75021,034Jun 13, 2013, 05:35 PM
Segal Lloyd MitchellDirectorJun 11, 2013 Buy$86.7330026,01918,534Jun 13, 2013, 05:35 PM
Provencio Norma AnnDirectorJun 11, 2013 Sale$85.266,000511,557171,860Jun 13, 2013, 05:14 PM
Morfit G MasonDirectorJun 04, 2013 Option Exercise$88.211,360119,96616,656Jun 06, 2013, 06:12 PM
Provencio Norma AnnDirectorJun 04, 2013 Option Exercise$88.211,362120,142177,860Jun 06, 2013, 06:01 PM
POWER ROBERT NDirectorJun 04, 2013 Option Exercise$88.211,461128,87511,623Jun 06, 2013, 05:54 PM
INGRAM ROBERT ALEXANDERDirectorJun 04, 2013 Option Exercise$88.211,279112,82163,787Jun 06, 2013, 05:45 PM
MELAS KYRIAZI THEODirectorJun 04, 2013 Option Exercise$88.2192481,506215,341Jun 06, 2013, 05:38 PM
STEVENSON KATHARINE BERGHUISDirectorJun 04, 2013 Option Exercise$88.214,101361,74918,732Jun 06, 2013, 05:27 PM
STEVENSON KATHARINE BERGHUISDirectorMay 30, 2013 Option Exercise$90.813,873351,70722,833Jun 03, 2013, 09:22 PM
Farmer Ronald HaroldDirectorMay 30, 2013 Option Exercise$90.812,177197,69323,264Jun 03, 2013, 09:07 PM
Provencio Norma AnnDirectorMay 30, 2013 Option Exercise$90.815,798526,516179,222Jun 03, 2013, 08:55 PM
MELAS KYRIAZI THEODirectorMay 30, 2013 Option Exercise$90.816,762614,057216,265Jun 03, 2013, 08:39 PM
Morfit G MasonDirectorMay 30, 2013 Option Exercise$90.8168,1126,185,25118,016Jun 03, 2013, 08:27 PM
POWER ROBERT NDirectorMay 30, 2013 Option Exercise$90.814,397399,29213,084Jun 03, 2013, 07:56 PM
INGRAM ROBERT ALEXANDERDirectorMay 30, 2013 Option Exercise$90.81127,12811,544,49365,066Jun 03, 2013, 07:40 PM
Segal Lloyd MitchellDirectorMay 30, 2013 Option Exercise$90.814,397399,29218,474Jun 03, 2013, 07:34 PM
Kornwasser LaizerEVP, Company Group ChairmanMar 11, 2013 Buy$70.612,000141,2172,000Mar 13, 2013, 06:03 PM
Segal Lloyd MitchellDirectorNov 09, 2012 Buy$54.2824013,02717,849Nov 14, 2012, 09:40 PM
Segal Lloyd MitchellDirectorNov 09, 2012 Buy$54.2824013,02717,849Nov 14, 2012, 09:21 PM
DE SILVA RAJIVPres & COO, Specialty PharmNov 08, 2012 Option Exercise$25.4276,3441,940,664341,561Nov 09, 2012, 03:53 PM
DE SILVA RAJIVPres & COO, Specialty PharmNov 08, 2012 Sale$54.0476,3444,125,676265,217Nov 09, 2012, 03:53 PM
DE SILVA RAJIVPres. & COO, Specialty PharmaNov 06, 2012 Option Exercise$11.89220,6942,623,153485,911Nov 08, 2012, 04:40 PM
DE SILVA RAJIVPres. & COO, Specialty PharmaNov 06, 2012 Sale$54.38220,69412,000,885364,857Nov 08, 2012, 04:40 PM
Stolz Brian M.EVP, Administration and CHCONov 07, 2012 Buy$52.762,040107,62226,650Nov 08, 2012, 02:29 PM
Schiller Howard BradleyEVP and CFONov 06, 2012 Buy$54.1018,300990,103182,900Nov 08, 2012, 02:23 PM
Segal Lloyd MitchellDirectorNov 06, 2012 Buy$54.4474540,55617,609Nov 08, 2012, 02:17 PM
ValueAct Holdings, L.P.DirectorJun 07, 2012 Buy$48.782,807136,92517,559,302Jun 07, 2012, 05:38 PM
ValueAct Holdings, L.P.DirectorJun 06, 2012 Buy$48.2050,0002,410,00017,556,495Jun 07, 2012, 05:38 PM
ValueAct Holdings, L.P.DirectorJun 05, 2012 Buy$47.55100,0004,755,00017,506,495Jun 07, 2012, 05:38 PM
PAUL LAURENCE EDirectorJun 01, 2012 Buy$46.854,300201,45560,459Jun 05, 2012, 04:57 PM
ValueAct Holdings, L.P.DirectorJun 04, 2012 Buy$46.46100,0004,646,00017,406,495Jun 04, 2012, 04:59 PM
ValueAct Holdings, L.P.DirectorJun 01, 2012 Buy$46.90100,0004,690,00017,306,495Jun 04, 2012, 04:59 PM
ValueAct Holdings, L.P.DirectorMay 31, 2012 Buy$47.9250,0002,396,00017,206,495Jun 04, 2012, 04:59 PM
PAUL LAURENCE EDirectorMay 29, 2012 Buy$48.0070033,60048,097May 30, 2012, 04:51 PM
PAUL LAURENCE EDirectorMay 25, 2012 Buy$48.605,000243,00047,397May 30, 2012, 04:51 PM
ValueAct Holdings, L.P.DirectorMay 30, 2012 Buy$47.8597,1934,650,68517,156,495May 30, 2012, 04:38 PM
ValueAct Holdings, L.P.DirectorMay 29, 2012 Buy$48.3450,0002,417,00017,059,302May 30, 2012, 04:38 PM
ValueAct Holdings, L.P.DirectorMay 25, 2012 Buy$48.5750,0002,428,50017,009,302May 30, 2012, 04:38 PM
ValueAct Holdings, L.P.DirectorMay 24, 2012 Buy$47.70100,0004,770,00016,959,302May 24, 2012, 05:56 PM
ValueAct Holdings, L.P.DirectorMay 23, 2012 Buy$46.29100,0004,629,00016,859,302May 24, 2012, 05:56 PM
ValueAct Holdings, L.P.DirectorMay 22, 2012 Buy$47.54100,0004,754,00016,759,302May 24, 2012, 05:56 PM
Provencio Norma AnnDirectorMay 22, 2012 Buy$47.744,225201,714168,155May 24, 2012, 05:00 PM
ValueAct Holdings, L.P.DirectorMay 21, 2012 Buy$47.16100,0004,716,00016,659,302May 21, 2012, 08:19 PM
ValueAct Holdings, L.P.DirectorMay 18, 2012 Buy$47.72250,00011,930,00016,559,302May 21, 2012, 08:19 PM
ValueAct Holdings, L.P.DirectorMay 17, 2012 Buy$48.67500,00024,336,00016,309,302May 21, 2012, 08:19 PM
PAUL LAURENCE EDirectorMay 18, 2012 Buy$47.005,000235,00042,397May 21, 2012, 05:05 PM
Farmer Ronald HaroldDirectorMay 17, 2012 Buy$49.342,00098,68010,847May 21, 2012, 04:54 PM
ValueAct Holdings, L.P.DirectorMay 14, 2012 Buy$50.98295,00015,039,10015,809,302May 16, 2012, 07:05 PM
PAUL LAURENCE EDirectorMay 14, 2012 Buy$51.035,000255,14337,397May 14, 2012, 05:57 PM
Masterson Richard KevinPres. & COO, Valeant Intl. BBMay 10, 2012 Sale$52.57421089,524May 14, 2012, 05:33 PM
Stolz Brian M.EVP, Administration and CHCOMay 10, 2012 Buy$53.105,000265,50620,260May 14, 2012, 05:16 PM
ValueAct Holdings, L.P.DirectorMay 08, 2012 Buy$51.00419,00021,369,00015,514,302May 10, 2012, 04:36 PM
Hall SusanGlobal Head of R&DMar 07, 2012 Option Exercise$13.2416,120213,42916,120Mar 08, 2012, 07:15 PM
Hall SusanGlobal Head of R&DMar 07, 2012 Sale$54.5016,120878,5130Mar 08, 2012, 07:15 PM
Schiller Howard BradleyCFOMar 06, 2012 Buy$53.539,200492,454136,800Mar 08, 2012, 07:00 PM
Schiller Howard BradleyEVP and CFOMar 01, 2012 Buy$53.479,300497,287118,300Mar 05, 2012, 05:18 PM
Schiller Howard BradleyEVP and CFOMar 02, 2012 Buy$53.819,300500,440127,600Mar 05, 2012, 05:18 PM
Schiller Howard BradleyEVP and CFODec 08, 2011 Buy$45.5111,000500,60654,500Dec 09, 2011, 05:19 PM
Schiller Howard BradleyEVP and CFODec 05, 2011 Buy$46.8211,000515,02043,500Dec 07, 2011, 03:55 PM
Schiller Howard BradleyEVP and CFODec 01, 2011 Buy$46.0521,500990,07521,500Dec 05, 2011, 05:29 PM
Schiller Howard BradleyEVP and CFODec 02, 2011 Buy$46.2611,000508,86032,500Dec 05, 2011, 05:29 PM
Stolz Brian M.EVP Administration & CHCONov 17, 2011 Buy$42.052,400100,92012,860Nov 18, 2011, 03:05 PM
Farmer Ronald HaroldDirectorSep 12, 2011 Buy$39.721,00039,7208,209Sep 14, 2011, 01:02 PM
Stolz Brian M.EVP, Administration and CHCOAug 26, 2011 Buy$41.002,680109,8805,230Aug 30, 2011, 04:42 PM
Farmer Ronald HaroldDirectorAug 19, 2011 Buy$38.571,00038,5707,209Aug 24, 2011, 12:15 PM
Farmer Ronald HaroldDirectorAug 19, 2011 Buy$38.571,00038,5706,209Aug 24, 2011, 10:21 AM
DE SILVA RAJIVPresident & COOAug 12, 2011 Buy$40.406,180249,666241,758Aug 16, 2011, 04:43 PM
Pearson J. MichaelChief Executive OfficerAug 11, 2011 Buy$38.62155,6426,010,7705,570,503Aug 15, 2011, 06:56 PM
Masterson Richard KevinPres.&COO, Valeant Int.(BB)SRLMay 02, 2011 Option Exercise$52.632,036107,15532,671Aug 15, 2011, 06:47 PM
Masterson Richard KevinPres.&COO, Valeant Int.(BB)SRLAug 11, 2011 Option Exercise$9.4242,469400,05875,140Aug 15, 2011, 06:47 PM
Provencio Norma AnnDirectorAug 09, 2011 Buy$40.872,25592,154162,013Aug 11, 2011, 04:49 PM
Stolz Brian M.EVP, Administration and CHCOAug 11, 2011 Buy$39.211,80070,5762,550Aug 11, 2011, 04:18 PM
Stolz Brian M.EVP, Administration and CHCOAug 09, 2011 Buy$39.1075029,325750Aug 11, 2011, 04:18 PM
Farmer Ronald HaroldDirectorAug 10, 2011 Buy$38.591,00038,5906,209Aug 11, 2011, 03:46 PM
Farmer Ronald HaroldDirectorAug 09, 2011 Buy$38.661,00038,6605,209Aug 11, 2011, 03:46 PM
STEVENSON KATHARINE BERGHUISDirectorAug 08, 2011 Buy$39.731,00039,73010,397Aug 09, 2011, 05:03 PM
Loberg Philip Walden JrEVP, Interim CFOJun 09, 2011 Buy$52.827,500396,150137,565Jun 13, 2011, 02:52 PM
DE SILVA RAJIVPresident,VPII&COO,Spec.PharmaJun 01, 2011 Option Exercise$52.3631,4421,646,303220,738Jun 03, 2011, 06:52 PM
DE SILVA RAJIVPresident,VPII&COO,Spec.PharmaJun 01, 2001 Option Exercise$13.7513,505185,694225,278Jun 03, 2011, 06:52 PM
DE SILVA RAJIVPresident,VPII&COO,Spec.PharmaJun 01, 2011 Option Exercise$8.1169,581564,302238,675Jun 03, 2011, 06:52 PM
Chai-Onn Robert RoswellEVP, GC & Corp. Sec.May 27, 2011 Buy$50.7610,000507,600167,774Jun 01, 2011, 06:46 PM
ValueAct Holdings, L.P.DirectorMay 13, 2011 Sale$49.994,498,180224,864,02615,095,302May 17, 2011, 07:04 PM
Provencio Norma AnnDirectorMay 16, 2011 Buy$49.851,00049,850155,007May 17, 2011, 04:02 PM
Provencio Norma AnnDirectorMay 13, 2011 Buy$51.241,00051,240154,007May 17, 2011, 04:02 PM
Durham Mark AndrewSVP Human ResourcesMay 11, 2011 Option Exercise$24.5050,0001,225,000111,595May 13, 2011, 01:48 PM
Durham Mark AndrewSVP Human ResourcesMay 11, 2011 Sale$52.1750,0002,608,50061,595May 13, 2011, 01:48 PM
Masterson Richard KevinPres.&COO,Valeant Int(BB)SRLApr 26, 2011 Option Exercise$52.192,124110,85234,707Apr 28, 2011, 09:57 PM
Pearson J. MichaelChief Executive OfficerApr 21, 2011 Option Exercise$54.05235,79312,744,6115,414,861Apr 26, 2011, 09:40 PM
Provencio Norma AnnDirectorMar 04, 2011 Buy$39.871,57562,801153,007Apr 11, 2011, 05:56 PM
Provencio Norma AnnDirectorNov 10, 2010 Buy$24.755,000123,750148,009Apr 11, 2011, 04:23 PM
INGRAM ROBERT ALEXANDERDirectorFeb 28, 2011 Sale$40.009,872394,880217,724Apr 11, 2011, 12:10 PM
STEVENSON KATHARINE BERGHUISDirectorMar 14, 2011 Buy$40.592,00081,1805,000Mar 16, 2011, 12:23 PM
ValueAct Holdings, L.P.DirectorMar 10, 2011 Sale$37.307,366,419274,767,42319,593,482Mar 14, 2011, 05:41 PM
Provencio Norma AnnDirectorMar 04, 2011 Buy$39.871,57562,801117,979Mar 08, 2011, 09:28 PM
INGRAM ROBERT ALEXANDERDirectorFeb 28, 2011 Sale$40.009,872394,8800Mar 03, 2011, 08:52 AM
Pearson J. MichaelChief Executive OfficerFeb 10, 2011 Option Exercise$39.50929,36436,709,8785,650,654Feb 14, 2011, 09:54 PM
Wells William McDowallDirectorDec 07, 2010 Option Exercise$26.122,15056,15892,390Dec 08, 2010, 06:51 PM
Wells William McDowallDirectorDec 07, 2010 Sale$28.0517,390487,78975,000Dec 08, 2010, 06:51 PM
Wells William McDowallDirectorDec 06, 2010 Sale$28.13490,46113,796,66875,000Dec 08, 2010, 06:51 PM
DE SILVA RAJIVPresident & COO Spec. Pharma.Dec 01, 2010 Option Exercise$8.1118,277148,226511,691Dec 02, 2010, 09:35 PM
DE SILVA RAJIVPresident & COO Spec. Pharma.Dec 01, 2010 Sale$27.00219,8975,937,219493,414Dec 02, 2010, 09:35 PM
Chouinard MichelCOO, Biovail Labs.Intl SRLNov 29, 2010 Option Exercise$22.0532,250711,11234,720Dec 01, 2010, 05:49 PM
Chouinard MichelCOO, Biovail Labs.Intl SRLNov 29, 2010 Sale$25.3032,250815,9252,470Dec 01, 2010, 05:49 PM
Chouinard MichelCOO, Biovail Labs.Intl SRLNov 15, 2010 Sale$25.16102,6582,582,8742,528Dec 01, 2010, 05:49 PM
STEVENSON KATHARINE BERGHUISDirectorNov 29, 2010 Buy$25.333,00075,9903,000Dec 01, 2010, 05:07 PM
Chai-Onn Robert RoswellEVP, GC & Corp. Sec.Nov 12, 2010 Option Exercise$6.7059,681399,86359,681Nov 16, 2010, 07:51 PM
Provencio Norma AnnDirectorNov 10, 2010 Option Exercise$24.751,00024,750108,891Nov 12, 2010, 06:23 PM
Provencio Norma AnnDirectorNov 10, 2010 Option Exercise$24.754,00099,0004,000Nov 12, 2010, 06:23 PM
Chai-Onn Robert RoswellEVP, GC & Corp. Sec.Nov 09, 2010 Sale$25.9535,607924,00218,511Nov 12, 2010, 06:04 PM
Wells William McDowallDirectorNov 09, 2010 Option Exercise$11.85375,1004,443,184725,641Nov 12, 2010, 11:48 AM
Wells William McDowallDirectorNov 09, 2010 Sale$25.86375,1009,700,086350,541Nov 12, 2010, 11:48 AM
Mulligan Margaret JeanEVP, CFONov 08, 2010 Option Exercise$26.1247,6441,244,46183,014Nov 10, 2010, 05:46 PM
Durham Mark AndrewSVP, Human ResourcesNov 08, 2010 Option Exercise$26.1246,6281,217,92357,280Nov 10, 2010, 05:19 PM
Durham Mark AndrewSVP, HR & Shared ServicesAug 20, 2010 Option Exercise$17.0060,0001,020,00061,250Aug 20, 2010, 02:49 PM
Durham Mark AndrewSVP, HR & Shared ServicesAug 20, 2010 Sale$22.2660,0001,335,6001,250Aug 20, 2010, 02:49 PM
Mayer ChristineSVP, BTA Pharmaceuticals, Inc.Aug 09, 2010 Option Exercise$17.4520,000349,00020,000Aug 10, 2010, 12:08 PM
Mayer ChristineSVP, BTA Pharmaceuticals, Inc.Aug 09, 2010 Sale$22.9220,000458,44018,000Aug 10, 2010, 12:08 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Paulson JohnDirector03/29/202462,493
ICAHN BRETTDirector03/29/202433,124
ROBERTSON RUSSEL CDirector03/29/202431,246
WECHSLER AMY BDirector03/29/20246,865
Barresi John SSVP, Controller & CAO03/01/202431,529
APPIO THOMASChief Executive Officer03/01/20241,156,952
Carson SeanaEVP, General Counsel03/01/2024239,763
Carson SeanaEVP, General Counsel03/04/202461,867
ROBERTSON RUSSEL CDirector12/29/202331,246
ICAHN BRETTDirector12/29/202333,123
Paulson JohnDirector12/29/202362,500
WECHSLER AMY BDirector12/29/20236,873
Carson SeanaEVP, General Counsel12/01/202312,446
Carson SeanaEVP, General Counsel12/05/20231,624
Carson SeanaEVP, General Counsel11/03/20232,528
Carson SeanaEVP, General Counsel11/06/2023327
WECHSLER AMY BDirector09/29/20236,872
ROBERTSON RUSSEL CDirector09/29/202331,244
Paulson JohnDirector09/29/202362,497
ICAHN BRETTDirector09/29/202333,118
Carson SeanaEVP, General Counsel09/05/2023428,664
Carson SeanaEVP, General Counsel09/06/202355,352
Barresi John SSVP, Controller & CAO09/05/202333,250
Vadaketh Tom GeorgeEVP, Chief Financial Officer09/05/2023366,966
APPIO THOMASChief Executive Officer09/01/2023119,379
WECHSLER AMY BDirector06/30/20236,872
ICAHN BRETTDirector06/30/202333,120
Paulson JohnDirector06/30/202362,496
ROBERTSON RUSSEL CDirector06/30/202331,248
Barresi John SSVP, Controller & CAO06/20/202314,275
WECHSLER AMY BDirector03/31/20236,869
ROBERTSON RUSSEL CDirector03/31/202333,291
Paulson JohnDirector03/31/202362,500
ICAHN BRETTDirector03/31/202329,840
DE SCHUTTER RICHARD UDirector03/31/202329,500
Carson SeanaEVP, General Counsel03/03/20237,285
Carson SeanaEVP, General Counsel03/06/20234,539
Carson SeanaEVP, General Counsel03/06/20234,539
Carson SeanaEVP, General Counsel03/03/202342,093
Carson SeanaEVP, General Counsel03/02/202355,445
APPIO THOMASChief Executive Officer03/03/202393,203
APPIO THOMASChief Executive Officer03/02/2023161,246
Vadaketh Tom GeorgeEVP, Chief Financial Officer03/02/202337,009
Carson SeanaEVP, General Counsel02/27/202321,456
Carson SeanaEVP, General Counsel02/28/20232,721
APPIO THOMASChief Executive Officer02/27/202360,549
Vadaketh Tom GeorgeEVP, Chief Financial Officer01/03/202339,627
DE SCHUTTER RICHARD UDirector12/30/202232,568
ICAHN BRETTDirector12/30/202228,819
Miller Steven DDirector12/30/202228,819
Paulson JohnDirector12/30/202262,499
ROBERTSON RUSSEL CDirector12/30/202234,370
WECHSLER AMY BDirector12/30/20226,870
Carson SeanaEVP, General Counsel12/01/202213,021
Carson SeanaEVP, General Counsel11/03/20222,154
ROBERTSON RUSSEL CDirector09/30/202234,374
Paulson JohnDirector09/30/202262,499
WECHSLER AMY BDirector09/30/20226,869
ROBERTSON RUSSEL CDirector09/30/202238,122
Paulson JohnDirector09/30/202218,823
Miller Steven DDirector09/30/202230,619
ICAHN BRETTDirector09/30/202230,619
DE SCHUTTER RICHARD UDirector09/30/202234,374
APPIO THOMASChief Executive Officer09/01/2022101,414
ROBERTSON RUSSEL CDirector06/30/202236,065
Paulson JohnDirector06/30/202218,818
ROBERTSON RUSSEL CDirector06/30/202238,122
WECHSLER AMY BDirector06/30/20226,872
Miller Steven DDirector06/30/202230,623
ICAHN BRETTDirector06/30/202230,623
DE SCHUTTER RICHARD UDirector06/30/202234,368
PAPA JOSEPH CDirector05/10/2022316,912
Spurr RobertU.S. President-Pharma Business04/14/202235,393
WECHSLER AMY BDirector03/31/20226,855
ROBERTSON RUSSEL CDirector03/31/202238,114
Miller Steven DDirector03/31/202230,619
ICAHN BRETTDirector03/31/202230,619
DE SCHUTTER RICHARD UDirector03/31/202234,366
Paulson JohnDirector03/31/202230,619
Spurr RobertU.S. President-Pharma Business03/15/2022107,581
ACKERMANN CHRISTINAEVP AND GENERAL COUNSEL03/10/202218,928
Gordon Joseph FPres&Co-Head Bausch&Lomb/Int'l03/08/202284,625
Spurr RobertU.S. President-Pharma Business03/03/202296,187
Munsch FrederickSVP, Controller and CAO03/03/202214,355
ACKERMANN CHRISTINAEVP AND GENERAL COUNSEL03/03/2022163,523
Eldessouky SamEVP & Chief Financial Officer03/03/202229,324
PAPA JOSEPH CCHAIRMAN & CEO03/03/2022298,501
Gordon Joseph FPres&Co-Head Bausch&Lomb/Int'l03/03/202296,187
APPIO THOMASCEO, Pharma Business03/03/2022131,366
Gordon Joseph FPres&Co-Head Bausch&Lomb/Int'l03/02/2022258,869
Spurr RobertU.S. President-Pharma Business03/02/2022861,105
Spurr RobertU.S. President-Pharma Business03/02/202237,275
PAPA JOSEPH CChairman & CEO02/28/2022123,067
PAPA JOSEPH CChairman & CEO02/26/2022321,006
PAPA JOSEPH CChairman & CEO02/27/20222,765,113
Gordon Joseph FPres&Co-Head Bausch&Lomb/Int'l02/26/202237,061
Gordon Joseph FPres&Co-Head Bausch&Lomb/Int'l02/27/2022193,558
Gordon Joseph FPres&Co-Head Bausch&Lomb/Int'l03/01/2022150,971
APPIO THOMASCEO, Pharma Business02/26/202253,375
APPIO THOMASCEO, Pharma Business02/27/2022272,330
Spurr RobertU.S. President-Pharma Business02/26/202239,642
Spurr RobertU.S. President-Pharma Business02/27/2022177,682
ACKERMANN CHRISTINAEVP AND GENERAL COUNSEL02/27/2022390,282
Munsch FrederickSVP, Controller and CAO02/26/20227,451
Munsch FrederickSVP, Controller and CAO02/27/202240,226
Eldessouky SamEVP & Chief Financial Officer02/26/202219,821
Eldessouky SamEVP & Chief Financial Officer02/27/202297,887
Spurr RobertU.S. President-Pharma Business02/15/202281,340
Spurr RobertU.S. President-Pharma Business01/18/202286,574
DE SCHUTTER RICHARD UDirector12/31/202134,374
WECHSLER AMY BDirector12/31/20216,875
ROBERTSON RUSSEL CDirector12/31/202138,102
Paulson JohnDirector12/31/202130,619
Miller Steven DDirector12/31/202130,619
ICAHN BRETTDirector12/31/202130,619
APPIO THOMASCEO, Pharma Business12/15/202184,760
Miller Steven DDirector11/30/2021241,699
Miller Steven DDirector11/30/20211,211,825
Spurr RobertU.S. President-Pharma Business10/01/20218,094
WECHSLER AMY BDirector09/30/20216,851
ROBERTSON RUSSEL CDirector09/30/202138,099
Paulson JohnDirector09/30/202130,607
Miller Steven DDirector09/30/202130,607
ICAHN BRETTDirector09/30/202130,607
DE SCHUTTER RICHARD UDirector09/30/202134,367
PAPA JOSEPH CCHAIRMAN & CEO09/14/2021143,587
PAPA JOSEPH CCHAIRMAN & CEO09/13/2021103,595
Spurr RobertPresident, Salix08/27/202136,998
ACKERMANN CHRISTINAEVP AND GENERAL COUNSEL08/27/2021145,242
VON ESCHENBACH ANDREW C.Director08/05/202136,316
DE SCHUTTER RICHARD UDirector08/04/2021250,123
ROBERTSON RUSSEL CDirector06/30/202138,116
Miller Steven DDirector06/30/202130,610
ICAHN BRETTDirector06/30/202130,610
DE SCHUTTER RICHARD UDirector06/30/202134,363
WECHSLER AMY BDirector03/31/20216,856
Paulson JohnDirector03/31/202130,216
Miller Steven DDirector03/31/20214,698
ICAHN BRETTDirector03/31/20213,999
DE SCHUTTER RICHARD UDirector03/31/202133,962
ACKERMANN CHRISTINAEVP AND GENERAL COUNSEL03/11/202126,125
PAPA JOSEPH CCHAIRMAN & CEO03/10/20217,622,269
Herendeen PaulEVP and CFO03/10/20211,962,342
Gordon Joseph FPres&Co-Head Bausch&Lomb/Int'l03/10/2021410,839
Eldessouky SamSVP, CHIEF ACCOUNTING OFFICER03/10/2021242,692
APPIO THOMASPres&Co-Head Bausch&Lomb/Int'l03/10/2021576,316
ACKERMANN CHRISTINAEVP AND GENERAL COUNSEL03/10/2021724,021
Spurr RobertPresident, Salix03/01/2021102,178
PAPA JOSEPH CCHAIRMAN & CEO03/01/2021885,793
Herendeen PaulEVP and CFO03/01/2021495,022
Gordon Joseph FPres&Co-Head Bausch&Lomb/Int'l03/01/2021104,094
Eldessouky SamSVP, CHIEF ACCOUNTING OFFICER03/01/202154,639
APPIO THOMASPres&Co-Head Bausch&Lomb/Int'l03/01/2021170,799
ACKERMANN CHRISTINAEVP AND GENERAL COUNSEL03/01/2021168,631
WECHSLER AMY BDirector12/31/20206,864
ROBERTSON RUSSEL CDirector12/31/202037,482
Paulson JohnDirector12/31/202029,994
DE SCHUTTER RICHARD UDirector12/31/202033,738
APPIO THOMASPres&Co-Head Bausch&Lomb/Int'l12/15/202066,447
Humphries William D.President, Ortho-Dermatologics12/04/20201,640,111
Humphries William D.President, Ortho-Dermatologics12/04/20202,266,398
Humphries William D.President, Ortho-Dermatologics11/24/2020311,442
Humphries William D.President, Ortho-Dermatologics11/23/202021,326
Humphries William D.President, Ortho-Dermatologics11/27/2020196,474
Humphries William D.President, Ortho-Dermatologics11/27/2020268,207
Humphries William D.President, Ortho-Dermatologics11/24/2020425,196
Humphries William D.President, Ortho-Dermatologics11/23/202029,115
Spurr RobertPresident, Salix10/02/20204,386
WECHSLER AMY BDirector09/30/20206,869
ROBERTSON RUSSEL CDirector09/30/202037,498
Paulson JohnDirector09/30/202029,992
DE SCHUTTER RICHARD UDirector09/30/202033,737
PAPA JOSEPH CCHAIRMAN & CEO09/15/202081,380
PAPA JOSEPH CCHAIRMAN & CEO09/14/202055,794
Herendeen PaulEVP and CFO09/15/202026,124
Humphries William D.President, Ortho-Dermatologics09/08/202091,635
Spurr RobertPresident, Salix08/28/202021,726
Humphries William D.President, Ortho-Dermatologics08/17/202079,831
ROBERTSON RUSSEL CDirector06/30/202037,495
Paulson JohnDirector06/30/202028,258
DE SCHUTTER RICHARD UDirector06/30/202032,008
WECHSLER AMY BDirector06/30/20206,859
ValueAct Holdings, L.P.Director06/05/202018,246,312
ValueAct Holdings, L.P.Director06/05/202018,246,312
Paulson JohnDirector05/13/202021,972,617
Paulson JohnDirector05/12/202035,421,081
Paulson JohnDirector05/14/202025,857,837
PAPA JOSEPH CCHAIRMAN & CEO05/04/20201,638,591
Hale David RobertDirector04/29/202011,301
DE SCHUTTER RICHARD UDirector04/29/202011,301
WECHSLER AMY BDirector03/31/20206,867
ROBERTSON RUSSEL CDirector03/31/202037,495
Paulson JohnDirector03/31/202027,497
DE SCHUTTER RICHARD UDirector03/31/202031,248
Ross Thomas W. Sr.Director03/12/202038,837
PAPA JOSEPH CCHAIRMAN & CEO03/09/2020387,508
Herendeen PaulEVP and CFO03/09/2020195,515
Gordon Joseph FPres&Co-Head Bausch&Lomb/Int'l03/09/202046,929
Eldessouky SamSVP, CHIEF ACCOUNTING OFFICER03/09/202036,659
APPIO THOMASPres&Co-Head Bausch&Lomb/Int'l03/09/202057,305
ACKERMANN CHRISTINAEVP AND GENERAL COUNSEL03/09/202070,069
ACKERMANN CHRISTINAEVP AND GENERAL COUNSEL03/10/202080,106
VON ESCHENBACH ANDREW C.Director03/10/202019,996
DE SCHUTTER RICHARD UDirector03/03/2020115,415
DE SCHUTTER RICHARD UDirector03/10/202069,377
PAPA JOSEPH CCHAIRMAN & CEO03/02/2020110,911
PAPA JOSEPH CCHAIRMAN & CEO02/28/2020226,534
Humphries William D.President, Ortho-Dermatologics02/28/202055,332
Herendeen PaulEVP and CFO02/28/2020175,161
Gordon Joseph FPres&Co-Head Bausch&Lomb/Int'l02/28/202061,076
Eldessouky SamSVP, CHIEF ACCOUNTING OFFICER02/28/202021,238
APPIO THOMASPres&Co-Head Bausch&Lomb/Int'l02/28/202068,334
ACKERMANN CHRISTINAEVP AND GENERAL COUNSEL02/28/202092,359
Humphries William D.President, Ortho-Dermatologics02/20/20201,495,837
Gordon Joseph FPres&Co-Head Bausch&Lomb/Int'l02/20/2020309,661
Eldessouky SamSVP, CHIEF ACCOUNTING OFFICER02/20/2020236,632
APPIO THOMASPres&Co-Head Bausch&Lomb/Int'l02/20/2020261,054
ACKERMANN CHRISTINAEVP AND GENERAL COUNSEL02/20/2020592,122
Gordon Joseph FPres&Co-Head Bausch&Lomb/Int'l01/07/202062,312
Eldessouky SamSVP, CHIEF ACCOUNTING OFFICER01/07/202049,837
APPIO THOMASPres&Co-Head Bausch&Lomb/Int'l01/07/202053,750
ACKERMANN CHRISTINAEVP AND GENERAL COUNSEL01/07/202098,851
Humphries William D.President, Ortho-Dermatologics01/03/2020435,605
WECHSLER AMY BDirector12/31/201931,865
ROBERTSON RUSSEL CDirector12/31/201937,490
Paulson JohnDirector12/31/201927,496
DE SCHUTTER RICHARD UDirector12/31/201931,236
APPIO THOMASPres&Co-Head Bausch&Lomb/Int'l12/16/2019103,447
WECHSLER AMY BDirector09/30/201931,857
ROBERTSON RUSSEL CDirector09/30/201937,495
Paulson JohnDirector09/30/201927,487
DE SCHUTTER RICHARD UDirector09/30/201931,246
PAPA JOSEPH CCHAIRMAN & CEO09/16/2019118,873
Herendeen PaulEVP and CFO09/16/201938,160
PAPA JOSEPH CCHAIRMAN & CEO09/13/2019699,300
Herendeen PaulEVP and CFO08/23/2019551,600
APPIO THOMASPres&Co-Head Bausch&Lomb/Int'l08/19/2019178,111
McKenna Mark C.President, Salix08/19/2019235,221
Humphries William D.President, Ortho-Dermatologics08/16/2019650,142
ACKERMANN CHRISTINAEVP AND GENERAL COUNSEL08/09/2019174,172
ACKERMANN CHRISTINAEVP AND GENERAL COUNSEL08/12/201976,726
ACKERMANN CHRISTINAEVP AND GENERAL COUNSEL07/11/201998,446
WECHSLER AMY BDirector06/28/201931,853
ROBERTSON RUSSEL CDirector06/28/201937,477
DE SCHUTTER RICHARD UDirector06/28/201931,248
Paulson JohnDirector06/28/201927,490
McKenna Mark C.President, Salix06/24/201945,568
Eldessouky SamSVP, CHIEF ACCOUNTING OFFICER06/04/2019132,050
Gordon Joseph FPres&Co-Head Bausch&Lomb/Int'l05/06/201916,292
McKenna Mark C.President, Salix05/06/201917,538
Hale David RobertDirector05/03/2019249,982
Hale David RobertDirector05/01/201994,425
WECHSLER AMY BDirector05/03/2019249,982
VON ESCHENBACH ANDREW C.Director05/03/2019249,982
Ross Thomas W. Sr.Director05/03/2019249,982
ROBERTSON RUSSEL CDirector05/03/2019249,982
POWER ROBERT NDirector05/03/2019249,982
Paulson JohnDirector05/03/2019249,982
KAVANAGH SARAH BDirector05/03/2019249,982
KARABELAS ARGERIS NDirector05/03/2019249,982
DE SCHUTTER RICHARD UDirector05/03/2019249,982
DE SCHUTTER RICHARD UDirector05/01/201994,425
WECHSLER AMY BDirector03/29/201931,863
ROBERTSON RUSSEL CDirector03/29/201937,495
Paulson JohnDirector03/29/201927,491
DE SCHUTTER RICHARD UDirector03/29/201931,246
PAPA JOSEPH CCHAIRMAN & CEO03/08/2019439,582
McKenna Mark C.President, Salix03/08/201922,947
Herendeen PaulEVP and CFO03/08/2019230,794
Gordon Joseph FPres&Co-Head Bausch&Lomb/Int'l03/08/201936,683
Eldessouky SamSVP, CHIEF ACCOUNTING OFFICER03/08/201928,673
APPIO THOMASPres&Co-Head Bausch&Lomb/Int'l03/08/201968,489
ACKERMANN CHRISTINAEVP AND GENERAL COUNSEL03/08/201985,523
PAPA JOSEPH CCHAIRMAN & CEO02/28/2019710,100
McKenna Mark C.President, Salix01/08/201925,288
Gordon Joseph FPres&Co-Head Bausch&Lomb/Int'l01/08/201946,091
Eldessouky SamSVP, CHIEF ACCOUNTING OFFICER01/08/201936,040
APPIO THOMASPres&Co-Head Bausch&Lomb/Int'l01/08/201936,593
ACKERMANN CHRISTINAEVP AND GENERAL COUNSEL01/08/201973,228
Humphries William D.President, Ortho-Dermatologics01/03/2019245,854
ROBERTSON RUSSEL CDirector12/31/201840,819
Paulson JohnDirector12/31/201827,483
WECHSLER AMY BDirector12/31/201831,695
DE SCHUTTER RICHARD UDirector12/31/201831,233
APPIO THOMASPres&Co-Head Bausch&Lomb/Int'l12/14/2018584,018
ACKERMANN CHRISTINAEVP AND GENERAL COUNSEL10/16/2018115,821
ACKERMANN CHRISTINAEVP AND GENERAL COUNSEL10/15/2018382,481
WECHSLER AMY BDirector09/28/201831,240
DE SCHUTTER RICHARD UDirector09/28/201831,240
Paulson JohnDirector09/28/201827,493
ROBERTSON RUSSEL CDirector09/28/201837,478
APPIO THOMASPres&Co-Head Bausch&Lomb/Int'l08/20/2018143,241
DE SCHUTTER RICHARD UDirector09/13/20182,995,000
Herendeen PaulEVP and CFO09/14/2018226,100
PAPA JOSEPH CCHAIRMAN & CEO09/14/2018669,600
Herendeen PaulEVP and CFO08/23/2018550,884
APPIO THOMASPres&Co-Head Bausch&Lomb/Int'l08/20/2018119,317
ACKERMANN CHRISTINAEVP AND GENERAL COUNSEL08/09/2018182,962
DE SCHUTTER RICHARD UDirector06/29/201831,235
DE SCHUTTER RICHARD UDirector05/15/2018218,000
Paulson JohnDirector06/29/201827,493
ROBERTSON RUSSEL CDirector06/29/201837,486
WECHSLER AMY BDirector06/29/201831,235
Eldessouky SamSVP, CHIEF ACCOUNTING OFFICER06/04/2018135,615
DE SCHUTTER RICHARD UDirector05/15/2018327,450
PAPA JOSEPH CCHAIRMAN & CEO05/03/20181,683,458
Hale David RobertDirector05/01/201868,558
DE SCHUTTER RICHARD UDirector05/01/201863,643
WECHSLER AMY BDirector03/30/201831,235
ROBERTSON RUSSEL CDirector03/30/201837,492
DE SCHUTTER RICHARD UDirector03/30/201831,235
Paulson JohnDirector03/30/201827,494
Herendeen PaulEVP and CFO03/13/2018241,470
PAPA JOSEPH CCHAIRMAN & CEO03/13/2018481,500
DE SCHUTTER RICHARD UDirector03/08/2018153,400
Paulson JohnDirector03/06/2018108,826,084
Paulson JohnDirector03/06/2018108,826,084
APPIO THOMASEVP, COMPANY GROUP CHAIRMAN01/08/201830,146
Eldessouky SamSVP, CHIEF ACCOUNTING OFFICER01/08/201843,550
APPIO THOMASEVP, COMPANY GROUP CHAIRMAN01/08/201837,134
ACKERMANN CHRISTINAEVP AND GENERAL COUNSEL01/08/201887,029
Humphries William D.EVP, COMPANY GROUP CHAIRMAN01/03/2018306,089
Paulson JohnDirector12/29/201727,492
ROBERTSON RUSSEL CDirector12/29/201737,487
DE SCHUTTER RICHARD UDirector12/29/201731,232
WECHSLER AMY BDirector12/29/201731,232
DE SCHUTTER RICHARD UDirector11/17/2017143,300
Paulson JohnDirector11/16/20174,955,506
Paulson JohnDirector11/16/20174,952,821
Paulson JohnDirector09/29/201726,654
WECHSLER AMY BDirector09/29/201731,239
ROBERTSON RUSSEL CDirector09/29/201737,487
DE SCHUTTER RICHARD UDirector09/29/201731,239
Herendeen PaulEVP and CFO08/23/2017242,855
DE SCHUTTER RICHARD UDirector08/21/2017143,296
APPIO THOMASEVP, COMPANY GROUP CHAIRMAN08/18/201780,471
ACKERMANN CHRISTINAEVP AND GENERAL COUNSEL08/09/201792,927
Paulson JohnDirector08/09/201714,283,704
ROBERTSON RUSSEL CDirector06/30/201737,489
WECHSLER AMY BDirector06/30/201731,244
DE SCHUTTER RICHARD UDirector06/30/201731,261
Eldessouky SamSVP, CHIEF ACCOUNTING OFFICER06/07/201777,049
DE SCHUTTER RICHARD UDirector05/11/2017278,000
APPIO THOMASEVP, COMPANY GROUP CHAIRMAN05/10/201731,791
DE SCHUTTER RICHARD UDirector05/08/201720,750
Hale David RobertDirector05/03/201737,896
ESHELMAN FREDRIC NDirector05/03/201747,373
WECHSLER AMY BDirector03/31/201727,134
ROBERTSON RUSSEL CDirector03/31/201734,491
INGRAM ROBERT ALEXANDERDirector03/31/201723,384
DE SCHUTTER RICHARD UDirector03/31/201723,428
DE SCHUTTER RICHARD UDirector03/15/2017108,000
Herendeen PaulEVP and CFO03/14/2017257,280
ValueAct Holdings, L.P.Director03/14/201732,465,001
Pershing Square Capital Management, L.P.Director03/13/2017199,258,752
DE SCHUTTER RICHARD UDirector01/03/2017170,536
WECHSLER AMY BDirector12/30/201624,989
ROBERTSON RUSSEL CDirector12/30/201633,744
INGRAM ROBERT ALEXANDERDirector12/30/201621,243
Whitaker Anne ClemEVP, Company Group Chairman12/05/2016108,216
Whitaker Anne ClemEVP, Company Group Chairman08/02/201619,632
Ross Thomas W. Sr.Director12/14/201673,650
Pershing Square Capital Management, L.P.Director12/12/201651,628,848
Whitaker Anne ClemEVP, Company Group Chairman12/05/2016117,090
Kellen AriEVP, Company Group Chairman12/05/2016358,776
Rosiello Robert L.EVP, Corp Dev & Strategy12/05/2016264,366
Rosiello Robert L.EVP, Corp Dev & Strategy11/04/201618,023
INGRAM ROBERT ALEXANDERDirector09/30/201621,236
ROBERTSON RUSSEL CDirector09/30/201633,781
WECHSLER AMY BDirector09/30/201624,992
KARABELAS ARGERIS NDirector08/11/201698,600
Rosiello Robert L.EVP, Chief Financial Officer08/03/201631,497
INGRAM ROBERT ALEXANDERDirector06/30/201621,751
ROBERTSON RUSSEL CDirector06/30/20166,284
WECHSLER AMY BDirector06/30/20164,531
Hale David RobertDirector07/01/2016809
ESHELMAN FREDRIC NDirector07/01/2016618
Ross Thomas W. Sr.Director06/13/201697,600
PAPA JOSEPH CCHAIRMAN & CEO06/10/20164,944,960
Schiller Howard BradleyChairman and CEO02/18/20164,946,622
Kellen AriEVP, Company Group Chairman01/26/2016295,147
Pearson J. MichaelChief Executive Officer11/05/2015101,825,973
Farmer Ronald HaroldDirector10/21/2015272,395
Farmer Ronald HaroldDirector08/26/2015110,000
Farmer Ronald HaroldDirector08/21/2015224,973
Rosiello Robert L.EVP, Chief Financial Officer07/31/2015181,104
Rosiello Robert L.EVP, Chief Financial Officer07/30/20151,821,362
Rosiello Robert L.Executive Vice President06/12/20152,999,379
UBBEN JEFFREY WDirector06/10/2015925,011,616
Farmer Ronald HaroldDirector06/09/2015116,025
Farmer Ronald HaroldDirector06/08/2015144,600
Mirovsky PavelEVP, Pres. & GM Valeant EMENA06/02/2015760,049
Mirovsky PavelEVP, Pres. & GM Valeant EMENA06/01/20155,101
Mirovsky PavelEVP, Pres. & GM Valeant EMENA06/02/20159,020,318
Mirovsky PavelEVP, Pres. & GM Valeant EMENA06/01/201524,000
Whitaker Anne ClemDirector05/26/20151,760,000
Chai-Onn Robert RoswellEVP, CLO, General Counsel05/04/20152,311,644
Chai-Onn Robert RoswellEVP, CLO, General Counsel05/05/2015133,023
Chai-Onn Robert RoswellEVP, CLO, General Counsel05/04/201520,237,433
GOGGINS COLLEEN ADirector03/27/201599,062
Chai-Onn Robert RoswellEVP, CLO, General Counsel03/03/2015133,029
Chai-Onn Robert RoswellEVP, CLO, General Counsel03/02/20152,311,669
Chai-Onn Robert RoswellEVP, CLO, General Counsel03/02/201518,189,074
Farmer Ronald HaroldDirector12/12/201480,240
UBBEN JEFFREY WDirector12/10/20146,964,500
UBBEN JEFFREY WDirector12/09/201428,050,000
STEVENSON KATHARINE BERGHUISDirector12/03/2014218,595
Farmer Ronald HaroldDirector11/24/2014163,950
UBBEN JEFFREY WDirector11/24/201429,872,500
Chai-Onn Robert RoswellEVP, Gen. Couns. & Corp. Secy.06/23/201465,809
Chai-Onn Robert RoswellEVP, Gen. Couns. & Corp. Secy.06/23/20141,241,674
Mirovsky PavelPresident of Valeant Europe06/02/20141,312,490
Chai-Onn Robert RoswellEVP, Gen. Couns. & Corp. Secy.05/13/201464,500
Chai-Onn Robert RoswellEVP, Gen. Couns. & Corp. Secy.05/13/20141,300,840
Weldon RyanEVP, Company Group Chairman04/28/2014696,539
Schiller Howard BradleyEVP, CFO04/28/2014591,820
Kornwasser LaizerEVP, Company Group Chairman04/28/20142,890,022
Provencio Norma AnnDirector04/01/2014660,885
Kornwasser LaizerEVP, Company Group Chairman03/21/2014334,858
Chai-Onn Robert RoswellEVP, Gen. Couns. & Corp. Secy.03/17/201432,250
Chai-Onn Robert RoswellEVP, Gen. Couns. & Corp. Secy.03/17/2014708,600
Provencio Norma AnnDirector03/03/2014708,075
Provencio Norma AnnDirector02/03/2014681,160
Kornwasser LaizerEVP, Company Group Chairman01/24/2014335,127
Provencio Norma AnnDirector01/13/2014664,995
Kornwasser LaizerEVP, Company Group Chairman12/30/2013335,098
Pearson J. MichaelChief Executive Officer12/14/201314,999,549
Kornwasser LaizerEVP, Company Group Chairman11/18/2013375,844
Farmer Ronald HaroldDirector11/06/2013161,970
Provencio Norma AnnDirector11/01/2013533,485
Kornwasser LaizerEVP, Company Group Chairman09/13/201399,018
Provencio Norma AnnDirector09/06/2013401,000
Provencio Norma AnnDirector09/03/2013498,400
Hassan FredDirector08/29/20135,049,459
Farmer Ronald HaroldDirector08/27/2013205,900
Farmer Ronald HaroldDirector08/28/201349,995
Chai-Onn Robert RoswellEVP, GC and Corp. Secretary08/23/2013499,673
Stolz Brian M.EVP, Administration and CHCO08/12/2013453,199
Kornwasser LaizerEVP, Company Group Chairman08/09/2013351,246
Morfit G MasonDirector06/19/2013114,999,985
Segal Lloyd MitchellDirector06/14/201311,963
Segal Lloyd MitchellDirector06/11/201333,717
Segal Lloyd MitchellDirector06/12/2013208,750
Segal Lloyd MitchellDirector06/11/201326,019
Provencio Norma AnnDirector06/11/2013511,557
Morfit G MasonDirector06/04/2013119,966
Provencio Norma AnnDirector06/04/2013120,142
POWER ROBERT NDirector06/04/2013128,875
INGRAM ROBERT ALEXANDERDirector06/04/2013112,821
MELAS KYRIAZI THEODirector06/04/201381,506
STEVENSON KATHARINE BERGHUISDirector06/04/2013361,749
STEVENSON KATHARINE BERGHUISDirector05/30/2013351,707
Farmer Ronald HaroldDirector05/30/2013197,693
Provencio Norma AnnDirector05/30/2013526,516
MELAS KYRIAZI THEODirector05/30/2013614,057
Morfit G MasonDirector05/30/20136,185,251
POWER ROBERT NDirector05/30/2013399,292
INGRAM ROBERT ALEXANDERDirector05/30/201311,544,493
Segal Lloyd MitchellDirector05/30/2013399,292
Kornwasser LaizerEVP, Company Group Chairman03/11/2013141,217
Segal Lloyd MitchellDirector11/09/201213,027
Segal Lloyd MitchellDirector11/09/201213,027
DE SILVA RAJIVPres & COO, Specialty Pharm11/08/20121,940,664
DE SILVA RAJIVPres & COO, Specialty Pharm11/08/20124,125,676
DE SILVA RAJIVPres. & COO, Specialty Pharma11/06/20122,623,153
DE SILVA RAJIVPres. & COO, Specialty Pharma11/06/201212,000,885
Stolz Brian M.EVP, Administration and CHCO11/07/2012107,622
Schiller Howard BradleyEVP and CFO11/06/2012990,103
Segal Lloyd MitchellDirector11/06/201240,556
ValueAct Holdings, L.P.Director06/07/2012136,925
ValueAct Holdings, L.P.Director06/06/20122,410,000
ValueAct Holdings, L.P.Director06/05/20124,755,000
PAUL LAURENCE EDirector06/01/2012201,455
ValueAct Holdings, L.P.Director06/04/20124,646,000
ValueAct Holdings, L.P.Director06/01/20124,690,000
ValueAct Holdings, L.P.Director05/31/20122,396,000
PAUL LAURENCE EDirector05/29/201233,600
PAUL LAURENCE EDirector05/25/2012243,000
ValueAct Holdings, L.P.Director05/30/20124,650,685
ValueAct Holdings, L.P.Director05/29/20122,417,000
ValueAct Holdings, L.P.Director05/25/20122,428,500
ValueAct Holdings, L.P.Director05/24/20124,770,000
ValueAct Holdings, L.P.Director05/23/20124,629,000
ValueAct Holdings, L.P.Director05/22/20124,754,000
Provencio Norma AnnDirector05/22/2012201,714
ValueAct Holdings, L.P.Director05/21/20124,716,000
ValueAct Holdings, L.P.Director05/18/201211,930,000
ValueAct Holdings, L.P.Director05/17/201224,336,000
PAUL LAURENCE EDirector05/18/2012235,000
Farmer Ronald HaroldDirector05/17/201298,680
ValueAct Holdings, L.P.Director05/14/201215,039,100
PAUL LAURENCE EDirector05/14/2012255,143
Masterson Richard KevinPres. & COO, Valeant Intl. BB05/10/2012210
Stolz Brian M.EVP, Administration and CHCO05/10/2012265,506
ValueAct Holdings, L.P.Director05/08/201221,369,000
Hall SusanGlobal Head of R&D03/07/2012213,429
Hall SusanGlobal Head of R&D03/07/2012878,513
Schiller Howard BradleyCFO03/06/2012492,454
Schiller Howard BradleyEVP and CFO03/01/2012497,287
Schiller Howard BradleyEVP and CFO03/02/2012500,440
Schiller Howard BradleyEVP and CFO12/08/2011500,606
Schiller Howard BradleyEVP and CFO12/05/2011515,020
Schiller Howard BradleyEVP and CFO12/01/2011990,075
Schiller Howard BradleyEVP and CFO12/02/2011508,860
Stolz Brian M.EVP Administration & CHCO11/17/2011100,920
Farmer Ronald HaroldDirector09/12/201139,720
Stolz Brian M.EVP, Administration and CHCO08/26/2011109,880
Farmer Ronald HaroldDirector08/19/201138,570
Farmer Ronald HaroldDirector08/19/201138,570
DE SILVA RAJIVPresident & COO08/12/2011249,666
Pearson J. MichaelChief Executive Officer08/11/20116,010,770
Masterson Richard KevinPres.&COO, Valeant Int.(BB)SRL05/02/2011107,155
Masterson Richard KevinPres.&COO, Valeant Int.(BB)SRL08/11/2011400,058
Provencio Norma AnnDirector08/09/201192,154
Stolz Brian M.EVP, Administration and CHCO08/11/201170,576
Stolz Brian M.EVP, Administration and CHCO08/09/201129,325
Farmer Ronald HaroldDirector08/10/201138,590
Farmer Ronald HaroldDirector08/09/201138,660
STEVENSON KATHARINE BERGHUISDirector08/08/201139,730
Loberg Philip Walden JrEVP, Interim CFO06/09/2011396,150
DE SILVA RAJIVPresident,VPII&COO,Spec.Pharma06/01/20111,646,303
DE SILVA RAJIVPresident,VPII&COO,Spec.Pharma06/01/2001185,694
DE SILVA RAJIVPresident,VPII&COO,Spec.Pharma06/01/2011564,302
Chai-Onn Robert RoswellEVP, GC & Corp. Sec.05/27/2011507,600
ValueAct Holdings, L.P.Director05/13/2011224,864,026
Provencio Norma AnnDirector05/16/201149,850
Provencio Norma AnnDirector05/13/201151,240
Durham Mark AndrewSVP Human Resources05/11/20111,225,000
Durham Mark AndrewSVP Human Resources05/11/20112,608,500
Masterson Richard KevinPres.&COO,Valeant Int(BB)SRL04/26/2011110,852
Pearson J. MichaelChief Executive Officer04/21/201112,744,611
Provencio Norma AnnDirector03/04/201162,801
Provencio Norma AnnDirector11/10/2010123,750
INGRAM ROBERT ALEXANDERDirector02/28/2011394,880
STEVENSON KATHARINE BERGHUISDirector03/14/201181,180
ValueAct Holdings, L.P.Director03/10/2011274,767,423
Provencio Norma AnnDirector03/04/201162,801
INGRAM ROBERT ALEXANDERDirector02/28/2011394,880
Pearson J. MichaelChief Executive Officer02/10/201136,709,878
Wells William McDowallDirector12/07/201056,158
Wells William McDowallDirector12/07/2010487,789
Wells William McDowallDirector12/06/201013,796,668
DE SILVA RAJIVPresident & COO Spec. Pharma.12/01/2010148,226
DE SILVA RAJIVPresident & COO Spec. Pharma.12/01/20105,937,219
Chouinard MichelCOO, Biovail Labs.Intl SRL11/29/2010711,112
Chouinard MichelCOO, Biovail Labs.Intl SRL11/29/2010815,925
Chouinard MichelCOO, Biovail Labs.Intl SRL11/15/20102,582,874
STEVENSON KATHARINE BERGHUISDirector11/29/201075,990
Chai-Onn Robert RoswellEVP, GC & Corp. Sec.11/12/2010399,863
Provencio Norma AnnDirector11/10/201024,750
Provencio Norma AnnDirector11/10/201099,000
Chai-Onn Robert RoswellEVP, GC & Corp. Sec.11/09/2010924,002
Wells William McDowallDirector11/09/20104,443,184
Wells William McDowallDirector11/09/20109,700,086
Mulligan Margaret JeanEVP, CFO11/08/20101,244,461
Durham Mark AndrewSVP, Human Resources11/08/20101,217,923
Durham Mark AndrewSVP, HR & Shared Services08/20/20101,020,000
Durham Mark AndrewSVP, HR & Shared Services08/20/20101,335,600
Mayer ChristineSVP, BTA Pharmaceuticals, Inc.08/09/2010349,000
Mayer ChristineSVP, BTA Pharmaceuticals, Inc.08/09/2010458,440
Load More Insider Transactions
FUNDS WITH A POSITION IN BAUSCH HEALTH COMPANIES INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
ICAHN CARL C34,721,1182.47%No changeActivists
PAULSON & CO. INC.26,439,03519.14%No changeEvent Driven, Other
OAKTREE CAPITAL MANAGEMENT LP1,300,0000.15%No changeOther
D. E. SHAW & CO., INC.798,6920.0056%-57.45%Other
GEODE CAPITAL MANAGEMENT, LLC429,2270.00043%40.78%Other
RENAISSANCE TECHNOLOGIES LLC265,2890.00329%NewOther
BLACKROCK INC.213,4850.00004%-9.44%Other
GABELLI FUNDS LLC67,0000.00414%-26.37%Event Driven, Growth, Activists
BRIDGEWATER ASSOCIATES, LP55,2230.00249%-38.75%Other
ELLIOTT INVESTMENT MANAGEMENT L.P.11,5000.00049%No changeActivists
TUDOR INVESTMENT CORP ET AL10,4230.00067%-39.31%Event Driven, Other
CHANGE IN SHARES OUTSTANDING FOR BAUSCH HEALTH COMPANIES INC
STOCK BUYBACKS FOR BAUSCH HEALTH COMPANIES INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
0.19%
1Q
12/31/2023
06/30/2023
-0.27%
2Q
12/31/2023
03/31/2023
0.77%
3Q
12/31/2023
12/31/2022
2.58%
4Q
12/31/2023
09/30/2022
0.74%
5Q
12/31/2023
06/30/2022
1.08%
6Q
12/31/2023
03/31/2022
1.47%
7Q
12/31/2023
12/31/2021
1.67%
8Q
12/31/2023
09/30/2021
0.58%
9Q
12/31/2023
06/30/2021
1.95%
10Q
12/31/2023
03/31/2021
2.61%
11Q
12/31/2023
12/31/2020
2.87%
12Q
12/31/2023
09/30/2020
2.32%
13Q
12/31/2023
06/30/2020
3.04%
14Q
12/31/2023
03/31/2020
3.59%
15Q
12/31/2023
12/31/2019
3.80%
16Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
0.19%
1Q
06/30/2023
-0.27%
2Q
03/31/2023
0.77%
3Q
12/31/2022
2.58%
4Q
09/30/2022
0.74%
5Q
06/30/2022
1.08%
6Q
03/31/2022
1.47%
7Q
12/31/2021
1.67%
8Q
09/30/2021
0.58%
9Q
06/30/2021
1.95%
10Q
03/31/2021
2.61%
11Q
12/31/2020
2.87%
12Q
09/30/2020
2.32%
13Q
06/30/2020
3.04%
14Q
03/31/2020
3.59%
15Q
12/31/2019
3.80%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR BAUSCH HEALTH COMPANIES INC
LOADING...